Agra Ventures Ltd (AGFAF)

[grunt1]

News Story



AgraFlora Organics Completes Acquisition of 100% Interest of Licensed Cannabis Producer AAA Heidelberg Inc.
19 Dec 2018 03:00 ET
CNW Group
AgraFlora Organics International Inc. (formerly PUF Ventures Inc.) (the "Company") (CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF), a growth oriented and diversified international cannabis company, is pleased to announce the acquisition of 100% interest in the London, Ontario based licensed cannabis producer, AAA Heidelberg Inc.

In conjunction with the acquisition the Company has issued 12,216,509 common shares (the "Shares") at a deemed price of $0.1667 per share to the shareholders of AAA Heidelberg Inc. ("AAA Heidelberg") pursuant to the share exchange agreement entered into between the Company, AAA Heidelberg and the shareholders of AAA Heidelberg dated January 26, 2015. The completed share transfer has resulted in the acquisition of the remaining interest of the AAA Heidelberg licensed facility and the entity is now a wholly owned subsidiary of AgraFlora Organics International Inc.

"This acquisition marks a very important milestone in AgraFlora's growth initiative and designation as an official licensed cannabis production company." said Derek Ivany, President and CEO of AgraFlora Organics International Inc. "This, combined with the Company's 2,200,000 square foot Delta Greenhouse facility places AgraFlora among the largest potential per square footage cannabis producers in Canada and we are focused on brining both facilities into revenue generating production in 2019."

AgraFlora's AAA Heidelberg personnel are currently working with Canopy Growth to initiate the first crop of high quality medical cannabis at the London, Ontario based facility.

In Delta, BC the Company continues the retrofit of the existing 2,200,000 square foot Delta Greenhouse Complex and operations are currently on schedule to complete 250,000 sq. ft. of flowering area by the end of the Q2 2019. AgraFlora intends on completing the total of 1,700,000 sq. ft. of flowering area by the end of 2019 and the final phase of the greenhouse retrofit is planned to include an additional 450,000 sq. ft. of flowering area scheduled for completion in the summer of 2020.

The shares issued pursuant to the Agreement and the debt settlements are subject to a four month hold period.

The acquisition of the remaining interest in licensed cannabis producer AAA Heidelberg follows AgraFlora's December 13, 2018 announcement of a supply agreement with Namaste Technologies Inc.'s wholly-owned subsidiary, Cannmart Inc. for the right of first refusal to purchase up to 10% of the total annual production from AgraFlora's large-scale Delta Greenhouse Complex. This represents up to 25,000,000 grams per year, at a price of $4 per gram.

As announced on December 10, 2018 the Company recently closed on a $7.5 million second tranche of a $40 million financing to be used exclusively to develop the Delta Greenhouse Complex. A total of $20 million have been raised with the remaining $20 million to be paid in two tranches of $5 million on January 15 and $15 million on March 1, 2018.

About AgraFlora Organics International Inc.

AgraFlora Organics International Inc. is a growth oriented and diversified company focused on the international cannabis industry. It owns an indoor cultivation operation in London, ON and is a joint venture partner in Propagation Service Canada and its large-scale 2,200,000 sq. ft. greenhouse complex in Delta, BC. The Company has a successful record of creating shareholder value and is actively pursuing other opportunities within the cannabis industry. For more information please visit: www.agraflora.com.

ON BEHALF OF THE BOARD OF DIRECTORS

Derek IvanyPresident & CEO

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.

SOURCE AgraFlora Organics International Inc.

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/December2018/19/c4231.html

SOURCE: AgraFlora Organics International Inc.
AgraFlora Organics International Inc., E: [e-mail], T: [phone]

Copyright (C) 2018 CNW Group. All rights reserved.




Chart not available

[grunt1]

AgraFlora Organics Provides Additional Information to Supply Agreement with Namaste Technologies



Canada NewsWire

VANCOUVER, Dec. 13, 2018


VANCOUVER, Dec. 13, 2018 /CNW/ - At the request of IIROC, AgraFlora Organics International Inc. (formerly PUF Ventures Inc.) ("AgraFlora Organics" or the "Company") (CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF), a growth oriented and diversified international cannabis company, is pleased to provide additional information to the news release earlier today announcing an agreement (the "Agreement") with Namaste Technologies Inc.'s ("Namaste") (TSXV: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF) wholly-owned subsidiary, Cannmart Inc. ("Cannmart"), where Cannmart may purchase medical cannabis products from AgraFlora's Propagation Services Canada (PSC) greenhouse operations in Delta, BC, subject to approval of its cultivation and sales licenses by Health Canada.


Agraflora Organics International (CNW Group/AgraFlora Organics International Inc.)

Subject to the terms of the Agreement, Cannmart reserves the right of first refusal to purchase up to 10% of the total annual production from AgraFlora's large-scale Delta Greenhouse Complex, representing 25,000,000 grams, at a price of $4 per gram, or up to $100,000,000 per year with production costs estimated to be between 20-24 percent of total revenue.

When the 2,200,000 sq. ft. Delta Greenhouse Complex is fully operational in 2021, it is projected to have an annual capacity of 250,000,000 grams of high quality cannabis.

For additional information regarding the Delta Greenhouse Complex and an interview with Master Grower Ruben Houweling please visit

.

About AgraFlora Organics International Inc.

AgraFlora Organics International Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies including AAA Heidelberg and Propagation Services Canada in Canada and is actively pursuing other opportunities within the cannabis industry. AgraFlora Organics has an option to purchase 100% of AAA Heidelberg Inc., a licensed producer under the Access to Cannabis for Medical Purposes Regulations. For more information please visit: www.agraflora.com.

ON BEHALF OF THE BOARD OF DIRECTORS

Derek Ivany
President & CEO

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.



SOURCE AgraFlora Organics International Inc.


View original content to download multimedia: http://www.newswire.ca/en/releases/archive/December2018/13/c2793.html

AgraFlora Organics International Inc., E: [e-mail], T: [phone]Copyright CNW Group 2018

[jk1283]

Agra teams up with Namaste

https://www.newswire.ca/news-releases/agraflora-organics-signs-supply-agreement-with-namaste-technologies-for-up-to-25000000-grams-of-medical-cannabis-annually-702655752.html

[grunt1]

AgraFlora Organics to Focus on Cannabis Flowering in its 2,200,000 Square Foot Greenhouse
12 Dec 2018 05:00 ET
CNW Group
AgraFlora Organics International Inc. (formerly PUF Ventures Inc.) ("AgraFlora Organics" or the "Company") (CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF), a growth oriented and diversified international cannabis company, is pleased to announce its joint venture company Propagation Services Canada is to focus on the cultivation of cannabis flowering plants and conduct propagation for its own internal needs.

"We have discovered the cannabis industry is not quite ready for outsourcing plant propagation and therefore will move to cultivate cannabis flowering plants due to the superior economics," said Derek Ivany, President and CEO of AgraFlora Organics International Inc. "The retrofit of the 2,200,000 square foot greenhouse is going very well, and we will be planting our first crop early next year. The economics of a 2,220,000 sq. ft. greenhouse complex producing approximately 0.12 kilogram per square foot of cannabis flower is staggering. We look forward to expanding our cultivation of cannabis flower to include the majority of our large-scale greenhouse floor space."

Propagation Services Canada is a joint venture between AgraFlora Organics, the Houweling's Group and Delta Organic Cannabis Corp. and is the process of retrofitting a large-scale greenhouse complex in Delta, BC. The 2,200,000 square foot complex will be readied for cannabis cultivation in three phases:
-- Phase 1 includes the retrofit of 350,000 square feet, including
100,000 post-production facilities, completion scheduled for Q2
2019;
-- Phase 2 includes an additional 1,450,000 square feet to be
completed by Q4 2019;
-- Phase 3 consists of 400,000 square feet scheduled for
completion in Q2 2020.




When completed early next year, the first phase of the retrofit will provide over 250,000 square feet of production space with an estimated annualized capacity of 30,000 kilograms of cannabis. Total production capacity is anticipated to be approximately 200,000 kilograms per year by late 2019 when the Phase 2 is completed, and in excess of 250,0000 kilograms annually when the third and final phase is completed in 2020.

The Delta greenhouse complex includes advanced growing systems for HVAC, watering and lighting. It includes its own natural gas co-gen energy plant which provides cost effective electricity for lighting and heating of the large-scale greenhouse. The result is a highly efficient and one of the most cost-effective growing operations in the industry.

Phase one of the retrofit includes site preparation for 250,000 square feet of flowering area, development of standard operation procedures, completion of security audit, development of overall security plan, and the ordering of long lead time items and planning with plant genetic experts in preparation for the first crop.

About AgraFlora Organics International Inc.

AgraFlora Organics International Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies including AAA Heidelberg and Propagation Services Canada in Canada and is actively pursuing other opportunities within the cannabis industry. AgraFlora Organics has an option to purchase 100% of AAA Heidelberg Inc., a licensed producer under the Access to Cannabis for Medical Purposes Regulations. For more information please visit www.agraflora.com and follow @agraflora on Twitter.

ON BEHALF OF THE BOARD OF DIRECTORS

Derek IvanyPresident & CEO

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.

SOURCE AgraFlora Organics International Inc.

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/December2018/12/c3655.html

SOURCE: AgraFlora Organics International Inc.
AgraFlora Organics International Inc., E: [e-mail], T: [phone]

Copyright (C) 2018 CNW Group. All rights reserved.




Chart not available

[Chi99RT]

Got my Fidelity and TDA shares today

[jk1283]

They stated since it’s on the OTC it sometimes takes a little longer. Probably within a week or two at most. With almost 4,000,000 sq ft of grow rooms, this will be a BEAST.
GL everyone.

[jk1283]

On the phone with them now. I’ll keep everyone updated.

[jk1283]

I use E*TRADE and it shows the name change but the share count stayed the same. Should I contact E*TRADE or will it settle it self?

[grunt1]

got them Thursday, was able to trade on Friday.
thanks

[jk1283]

Anyone get their shares yet?

[grunt1]

should happen very soon. I should be able to trade this stock by Thursday.

[jk1283]

Anyone still waiting on the 5/1 conversion? Hasn’t happened in E*TRADE yet.

[grunt1]

AgraFlora Organics Provides Update to 2,200,000 Square Foot Greenhouse Retrofit at Delta, BC and Equity Participation and Earn-In Agreement with Delta Organic Cannabis Corp.
19 Nov 2018 08:30 ET
CNW Group - CND
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/

AgraFlora Organics International Inc. (formerly PUF Ventures Inc.) ("AgraFlora Organics" or the "Company") (CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF), a growth oriented and diversified international cannabis company, is pleased to report on the progress of the retrofit of the large-scale greenhouse complex in Delta, BC. The retrofit of the 2,200,000 square foot complex has been split into three phases: Phase 1 includes the retrofit of 350,000 square feet, including post-production facilities, completion scheduled for Q1 2019; Phase 2 includes an additional 1,450,000 square feet to be completed by Q4 2019; and the final phase consisting of 400,000 square feet. Initial activities of the retrofit include site preparation for propagation operations including 250,000 square feet of flowering area, development of standard operation procedures and completion of security audit and development of overall plan, plus ordering of long lead time items and planning with plant genetic experts in preparation for the first crop.

"We are working aggressively to prepare the large-scale greenhouse complex in Delta, BC for the first 250,000 square feet of cannabis flowering and propagation plants," said Derek Ivany, President and CEO of AgraFlora Organics International Inc. "The retrofit of the 2,200,000 square foot greenhouse is on schedule and when completed and fully licensed will constitute the largest cannabis propagation operations in Canada and likely one of the largest cannabis flowering facilities in the world. We continue to work diligently toward our goal of becoming one of the premier cannabis companies in Canada."

The Company is also pleased to provide an update to the previously announced Equity Participation and Earn-In Agreement (the "Agreement") with Delta Organic Cannabis Corp. ("DOCC"), a privately held Toronto-based cannabis investment company backed by preeminent leaders in Canadian cannabis enterprise, for up to a $40 million investment at a price of approximately $0.45 per AGRA share for the development of a large-scale, 2,200,000 square foot commercial medical cannabis cultivation operation in Delta, British Columbia.

AGRA and DOCC have agreed to modify the Agreement payment terms announced on September 25, 2018 to the following draw down table:
-- October 18, 2018, DOCC advanced $12,500,000 for 5,572,755 PUF
Ventures Shares (pre-split);
-- November 30, 2018, DOCC to advance $7,500,000 for 16,718,265
post-split AgraFlora shares (3,343,653 pre-split shares);
-- January 15, 2019, DOCC to advance $5,000,000 for 11,145,510
post-split AgraFlora shares (2,229,102 pre-split shares);
-- March 1, 2019, DOCC to advance $15,000,000 for 33,436,530
post-split AgraFlora shares (6,687,306 pre-split shares).




Changes to the Agreement also result in modifications to the Earn-In Right to be exercised according to the following earn-in schedule from AGRA's current 50% portion of Propagation Services Canada Inc. ("PSC"):
-- DOCC has earned a 6.25% of PSC, by satisfaction of $12,500,000
of the defined subscription obligation;
-- DOCC shall earn an additional 3.75% (for a total of 10%) of PSC
by satisfaction of a further $7,500,000 of the defined
subscription obligations;
-- DOCC shall earn an additional 2.5% (for a total of 12.5%) of
PSC by satisfaction of a further $5,000,000 of the defined
subscription obligations;
-- DOCC shall earn an additional 7.5% (for a total of 20%) of PSC
by satisfaction of a further $15,000,000 of the defined
subscription obligations




The proceeds of the subscriptions are to be used exclusively to develop the Delta propagation complex consisting of 2,200,000 square feet of illuminated greenhouse space and 1,700,000 square feet of "ebb and flood" irrigation space. This is an arm's length transaction and no finder's fees are to be paid.

The Company, a 35% shareholder of Solaris Nutraceuticals, also reports the Australian Office of Drug Control (ODC) has rejected Solaris' application for both a medicinal cannabis license and cannabis research license due to management's failure to provide certain documents and information in a timely manner. Key members of the Solaris board are currently collecting the missing documentation and information and hope to be a position to submit the information within the 90-day appeal time frame.

About Delta Organic Cannabis Corp.

DOCC is Canadian focused vertically integrated cannabis company formed by some of the most successful early-movers in the space.

About AgraFlora Organics International Inc.

AgraFlora Organics International Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies including AAA Heidelberg and Propagation Services Canada in Canada and is actively pursuing other opportunities within the cannabis industry. AgraFlora Organics has an option to purchase 100% of AAA Heidelberg Inc., a licensed producer under the Access to Cannabis for Medical Purposes Regulations. For more information please visit www.agraflora.com and follow @agraflora on Twitter.

ON BEHALF OF THE BOARD OF DIRECTORS

Derek IvanyPresident & CEO

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.

SOURCE AgraFlora Organics International Inc.

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/November2018/19/c5109.html

SOURCE: AgraFlora Organics International Inc.
AgraFlora Organics International Inc., E: [e-mail], T: [phone]

Copyright (C) 2018 CNW Group. All rights reserved.




Chart not available

[grunt1]

AgraFlora Organics Provides Update to 2,200,000 Square Foot Greenhouse Retrofit at Delta, BC and Equity Participation and Earn-In Agreement with Delta Organic Cannabis Corp.
19 Nov 2018 08:30 ET
CNW Group - CND
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/

AgraFlora Organics International Inc. (formerly PUF Ventures Inc.) ("AgraFlora Organics" or the "Company") (CSE: AGRA) (Frankfurt: PU31) (OTCPK: PUFXF), a growth oriented and diversified international cannabis company, is pleased to report on the progress of the retrofit of the large-scale greenhouse complex in Delta, BC. The retrofit of the 2,200,000 square foot complex has been split into three phases: Phase 1 includes the retrofit of 350,000 square feet, including post-production facilities, completion scheduled for Q1 2019; Phase 2 includes an additional 1,450,000 square feet to be completed by Q4 2019; and the final phase consisting of 400,000 square feet. Initial activities of the retrofit include site preparation for propagation operations including 250,000 square feet of flowering area, development of standard operation procedures and completion of security audit and development of overall plan, plus ordering of long lead time items and planning with plant genetic experts in preparation for the first crop.

"We are working aggressively to prepare the large-scale greenhouse complex in Delta, BC for the first 250,000 square feet of cannabis flowering and propagation plants," said Derek Ivany, President and CEO of AgraFlora Organics International Inc. "The retrofit of the 2,200,000 square foot greenhouse is on schedule and when completed and fully licensed will constitute the largest cannabis propagation operations in Canada and likely one of the largest cannabis flowering facilities in the world. We continue to work diligently toward our goal of becoming one of the premier cannabis companies in Canada."

The Company is also pleased to provide an update to the previously announced Equity Participation and Earn-In Agreement (the "Agreement") with Delta Organic Cannabis Corp. ("DOCC"), a privately held Toronto-based cannabis investment company backed by preeminent leaders in Canadian cannabis enterprise, for up to a $40 million investment at a price of approximately $0.45 per AGRA share for the development of a large-scale, 2,200,000 square foot commercial medical cannabis cultivation operation in Delta, British Columbia.

AGRA and DOCC have agreed to modify the Agreement payment terms announced on September 25, 2018 to the following draw down table:
-- October 18, 2018, DOCC advanced $12,500,000 for 5,572,755 PUF
Ventures Shares (pre-split);
-- November 30, 2018, DOCC to advance $7,500,000 for 16,718,265
post-split AgraFlora shares (3,343,653 pre-split shares);
-- January 15, 2019, DOCC to advance $5,000,000 for 11,145,510
post-split AgraFlora shares (2,229,102 pre-split shares);
-- March 1, 2019, DOCC to advance $15,000,000 for 33,436,530
post-split AgraFlora shares (6,687,306 pre-split shares).




Changes to the Agreement also result in modifications to the Earn-In Right to be exercised according to the following earn-in schedule from AGRA's current 50% portion of Propagation Services Canada Inc. ("PSC"):
-- DOCC has earned a 6.25% of PSC, by satisfaction of $12,500,000
of the defined subscription obligation;
-- DOCC shall earn an additional 3.75% (for a total of 10%) of PSC
by satisfaction of a further $7,500,000 of the defined
subscription obligations;
-- DOCC shall earn an additional 2.5% (for a total of 12.5%) of
PSC by satisfaction of a further $5,000,000 of the defined
subscription obligations;
-- DOCC shall earn an additional 7.5% (for a total of 20%) of PSC
by satisfaction of a further $15,000,000 of the defined
subscription obligations




The proceeds of the subscriptions are to be used exclusively to develop the Delta propagation complex consisting of 2,200,000 square feet of illuminated greenhouse space and 1,700,000 square feet of "ebb and flood" irrigation space. This is an arm's length transaction and no finder's fees are to be paid.

The Company, a 35% shareholder of Solaris Nutraceuticals, also reports the Australian Office of Drug Control (ODC) has rejected Solaris' application for both a medicinal cannabis license and cannabis research license due to management's failure to provide certain documents and information in a timely manner. Key members of the Solaris board are currently collecting the missing documentation and information and hope to be a position to submit the information within the 90-day appeal time frame.

About Delta Organic Cannabis Corp.

DOCC is Canadian focused vertically integrated cannabis company formed by some of the most successful early-movers in the space.

About AgraFlora Organics International Inc.

AgraFlora Organics International Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies including AAA Heidelberg and Propagation Services Canada in Canada and is actively pursuing other opportunities within the cannabis industry. AgraFlora Organics has an option to purchase 100% of AAA Heidelberg Inc., a licensed producer under the Access to Cannabis for Medical Purposes Regulations. For more information please visit www.agraflora.com and follow @agraflora on Twitter.

ON BEHALF OF THE BOARD OF DIRECTORS

Derek IvanyPresident & CEO

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.

SOURCE AgraFlora Organics International Inc.

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/November2018/19/c5109.html

SOURCE: AgraFlora Organics International Inc.
AgraFlora Organics International Inc., E: [e-mail], T: [phone]

Copyright (C) 2018 CNW Group. All rights reserved.




Chart not available

[grunt1]

AgraFlora Organics Announces Completion of Name Change and Forward Split
14 Nov 2018 15:05 ET
CNW Group
AgraFlora Organics International Inc. (formerly PUF Ventures Inc.) ("AgraFlora Organics" or the "Company") (CSE: AGRA) (Frankfurt: PU3) (OTCPK: PUFXF), announces that, further to its news release of November 7, 2018, it has completed the name change from "PUF Ventures Inc." to "AgraFlora Organics International Inc." to better reflect the direction of the Company's business.

The Company's trading symbol has changed to "AGRA" on the Canadian Securities Exchange (the "CSE") and will remain as "PU3" on the Frankfurt Stock Exchange and as "PUFXF" on the OTC Pink sheets. The new CUSIP number for the Company's common shares is 00851F106 and ISIN is CA00851F1062.

The Company has been advised by the CSE that the common shares will commence trading under the new name effective at the opening of trading on November 15, 2018.

The Company is also pleased to announce that, following the name change, the Company will have completed a subdivision (the "Stock Split") of its issued and outstanding common shares on the basis of five (5) new common shares for every one (1) common share held by the shareholders of record (the "Registered Holders") as at November 19, 2018 (the "Record Date"). Consequently, Registered Holders as of the Record Date will receive five additional common shares for each common share held. In accordance with the Company's Articles, shareholder approval was not required for the Stock Split.

The Company's common shares are expected to commence trading on a split-adjusted basis on November 16, 2018.

"As we initiate cultivation at our AAA Heidelberg facility in London, ON and work toward the launch of our large-scale 2.2 million square foot greenhouse in Delta, BC, we felt it was necessary to change to a name more fitting to our goal of becoming a global leader in the cannabis sector," said Derek Ivany, President & CEO, AgraFlora Organics International Inc. "In addition to the name change to AgraFlora, the forward split is also a positive event for the Company as it provides for much greater liquidity for shareholders and allows for more transparent and consistent market."

Registered Holders do not need to take any action. The Company's transfer agent will send to all Registered Holders a notice under the direct registration system indicating the number of additional common shares that they received as a result of the Stock Split. These additional common shares will be held in book-entry form and registered electronically in the transfer agent's recordkeeping system, unless a physical share certificate is requested by the Registered Holder. Currently outstanding share certificates representing common shares of the Company will continue to be effective. They should be retained by Registered Holders and should not be forwarded to the Company or its transfer agent. Non-registered shareholders will have their brokerage accounts automatically updated to reflect the Stock Split.

After giving effect to the Stock Split, the Company will have approximately 340,671,315 common shares outstanding. The Company's authorized share capital will remain unchanged.

Outstanding stock options and share purchase warrants will also be adjusted by the Stock Split ratio and the respective exercise prices of outstanding stock options and share purchase warrants will be adjusted accordingly.

About AgraFlora Organics International Inc.

AgraFlora Organics International Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies including AAA Heidelberg and Propagation Services Canada in Canada, a large-scale greenhouse project in Australia and is actively pursuing other opportunities within the cannabis industry. AgraFlora Organics has an option to purchase 100% of AAA Heidelberg Inc., a licensed producer under the Access to Cannabis for Medical Purposes Regulations. For more information please visit: www.agraflora.com.

ON BEHALF OF THE BOARD OF DIRECTORS

Derek IvanyPresident & CEO

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.

SOURCE AgraFlora Organics International Inc.

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/November2018/14/c3957.html

SOURCE: AgraFlora Organics International Inc.
AgraFlora Organics International Inc., E: [e-mail], T: [phone]

Copyright (C) 2018 CNW Group. All rights reserved.




Chart not available

[grunt1]

PUF Ventures Announces Proposed Name Change and Forward Split
07 Nov 2018 12:59 ET
CNW Group
PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), announces that it intends to change its name to "AgraFlora Organics International Inc." to better reflect the direction of the Company's business.

Concurrent with the name change, the Company will be completing a subdivision of its issued and outstanding common shares (the "Shares") on the basis of five (5) new Shares for every one (1) Share held.

About PUF Ventures Inc.

PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies including AAA Heidelberg and Propagation Services Canada in Canada, a large-scale greenhouse project in Australia and actively pursuing other opportunities within the cannabis industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., an advanced applicant for an ACMPR license. For more information please visit: www.puf.ca.

ON BEHALF OF THE BOARD OF DIRECTORS

Derek IvanyPresident & CEO

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.

SOURCE PUF Ventures

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/November2018/07/c8271.html

SOURCE: PUF Ventures
PUF Ventures Inc., E: [e-mail], T: [phone]

Copyright (C) 2018 CNW Group. All rights reserved.




Chart not available

[grunt1]

yes, received them over the weekend.
thanks

[Expresso123]

Has anybody else received nature hemp Corp shares deposit in their account ?

[grunt1]

News Story



CSE: 2018-1102 - Plan of Arrangement - PUF Ventures Inc. (PUF)
01 Nov 2018 15:59 ET
GlobeNewswire
PUF Ventures Inc. ("PUF Ventures") has announced the completion of the arrangement and plan of arrangement (the "Arrangement") with Natures Hemp Corp. ("Natures Hemp"). In accordance with the Arrangement, the shareholders of PUF Ventures as at June 18, 2018, the record date for the special meeting that was held on August 7, 2018, will receive one common share of Natures Hemp for every 3.3665 common shares which they currently hold in PUF Ventures.

Disclosure documents are available at www.thecse.com

___________________________

PUF Ventures Inc. (<<PUF Ventures>>) a annonce la conclusion de l'arrangement et du plan d'arrangement (l '<<Arrangement>>) avec Natures Hemp Corp. (<<Natures Hemp>>). Conformement a l'arrangement, les actionnaires de PUF Ventures au 18 juin 2018, date de cloture des registres de l'assemblee extraordinaire tenue le 7 aout 2018, recevront une action ordinaire de Natures Hemp pour chaque tranche de 3,3665 actions ordinaires tenir dans PUF Ventures.

Les documents de divulgation sont disponibles sur www.thecse.com
Symbol(s)/Symbole(s): PUF
Ex-Distribution Date/ Date de distribution: June 15, 2018/ 15 juin 2018
Record Date/Date d'enregistrement: June 18, 2018/ 18 juin 2018
Distribution Date/ Date de distribution: August 28, 2018/ 28 aout 2018


If you have any questions or require further information please contact Listings at [phone] or E-mail: [e-mail]

Pour toute question, pour obtenir de l'information supplementaire veuillez communiquer avec le service des inscriptions au 416 367-7340 ou par courriel a l'adresse: [e-mail]

https://resource.globenewswire.com/media/02bcbc0c-7b2b-4503-8e3b-f55b7046b992/small/logo-en-png.png

<img src="http://www.globenewswire.com/newsroom/ti?ndecode=MTUwIzc0MjMyODg="; alt="" width="1" height="1"/>
(C) Copyright 2018 GlobeNewswire, Inc. All rights reserved.




Chart not available

[grunt1]

News Story



PUF Ventures Closes $12.5 Million First Tranche of $40 Million Equity Participation and Earn-In Agreement with Delta Organic Cannabis Corp.
18 Oct 2018 10:08 ET
CNW Group - CND
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./

PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), a growth oriented and diversified company focused on the international cannabis industry, announces that, further to its news releases dated September 25, 2018 and October 11, 2018, it has closed a $12.5 million first tranche of $40 million Equity Participation and Earn-In Agreement with Delta Organic Cannabis Corp. and issued the first tranche of 5,572,755 common shares (the "Shares") of the Company at a deemed price of $2.24 per Share.

"I am very please to report that we have received the first $12.5 million of a proposed $40 million financing to retrofit a 2.2 million square foot greenhouse for cannabis cultivation," said Derek Ivany, President and CEO, PUF Ventures Inc. "It has been a historic seven days for our Company with the granting of our license to produce from Health Canada, the legalization of cannabis in Canada and now the receipt of the initial funding from DOCC to retrofit a truly large-scale greenhouse in Delta, BC. These are significant milestones that have vaulted PUF Ventures into a prominent licensed producer. I have assembled a team of industry experts to oversee the retrofit and manage operations once complete and ensure the long-term success of the Company. I look forward to the days ahead as we move the Company from an applicant to a leading cannabis producer in Canada and around the world."

The Shares are being issued pursuant to the Equity Participation and Earn-In Agreement dated September 25, 2018 as amended on October 11, 2018, with Delta Organic Cannabis Corp., a privately held Toronto?based cannabis investment company backed by preeminent leaders in Canadian cannabis enterprise.

The Shares are subject to a statutory four-month hold period.

About PUF Ventures Inc.

PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies including AAA Heidelberg and Propagation Services Canada in Canada, a large-scale greenhouse project in Australia and actively pursuing other opportunities within the cannabis industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., an advanced applicant for an ACMPR license. For more information please visit: www.puf.ca.

ON BEHALF OF THE BOARD OF DIRECTORS

Derek Ivany President & CEO

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.

SOURCE PUF Ventures

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/October2018/18/c6727.html

SOURCE: PUF Ventures
PUF Ventures Inc., E: [e-mail], T: [phone]

Copyright (C) 2018 CNW Group. All rights reserved.

[grunt1]

Marijuana Stocks for Investors in the Cannabis Investor Magazine October 2018 Issue
17 Oct 2018 12:49 ET
ACCESSWIRE
ATLANTA, GA / ACCESSWIRE / October 17, 2018 / CannaInvestor Magazine, the leading industry investment magazine for cannabis investors, analysts, executives, entrepreneurs, and financial media, announced today that it has published its October 2018 issue of the Canadian CannaInvestor Magazine and the U.S. CannaInvestor Magazine. Both digital magazines are free to the public!

The content featured in the October 2018 Canadian CannaInvestor Magazine includes OrganiGram Holdings, Inc. (OGI) (OGRMF), PUF Ventures Inc. (PUF) (OTC PINK: PUFXF), Kontrol Energy Corp. (KNR) (OTC: OTSHF), Canadian Cannabis Stocks Technical Analysis, and the Top 25 Cannabis Companies. https://joom.ag/RbrY.

The content featured in the October 2018 U.S. CannaInvestor Magazine - Publicly Traded includes Kontrol Energy Corp. (OTSHF),Indiva Limited (NDVAF), GSRX Industries Inc. (GSRX), U.S. Cannabis Stocks Technical Analysis, and the Top 25 Cannabis Stocks. https://joom.ag/WTba.

The content featured in the October 2018 U.S. CannaInvestor Magazine - Privately Held includes Leafwire, Alternabis Farms, eXPO by Alliance Financial Network, and iaso Corp. https://joom.ag/mDVY.

Contact:

CannaInvestor Webcast & Magazine1-888-575-1254, Ext. [e-mail]@cannainvestormag.ca

SOURCE: CannaInvestor Magazine

https://www.accesswire.com/img.ashx?id=525557
Copyright 2018 ACCESSWIRE

[grunt1]

PUF Ventures Joins the Cannvas Marché Program as First Licensed Producer
16 Oct 2018 08:30 ET
CNW Group
PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), a growth oriented and diversified company focused on the international cannabis industry, is pleased to announce it has executed an agreement with Cannvas MedTech Inc. ("Cannvas" or the "Company") (CSE: MTEC) (Frankfurt: 3CM), a leading business technology company in the cannabis space, to become the first licensed producer to join the recently announced Cannvas Marché, a network of high-tech learning and fulfillment centres across Canada. PUF has secured premiere access to the digital experience screens to be presented in each Cannvas Marché location.

"I would like to welcome PUF Ventures as the first licensed producer to join our Cannvas Marché program," said Steve Loutskou, Chief Operating Officer of Cannvas MedTech Inc. "The response to the launch of the new brand and concept has been incredible, as there is a definite lack of quality, unbiased, physician-backed information regarding the potential health benefits of cannabis. We are committed to improving access to cannabis education through a network of locations across the country and are engaged in discussions with various government bodies to accelerate the rollout. We will look to attract other leading licensed producers to join the Cannvas Marché program and contribute to the overall digital experience for customers."

"We share the concerns of leading politicians about the delivery of cannabis and feel by putting education at the forefront of this industry, we can take steps to reduce the risks associated with cannabis," said Derek Ivany, President and CEO of PUF Ventures Inc. "The concept to provide accessible and unbiased cannabis education to consumers at the point of purchase will be very attractive to large cities like Toronto, Montreal and Vancouver. The timing for the launch of the Cannvas Marché concept could not be better with legalization upon us. I look forward to working with Steve and Shawn and the rest of the team at Cannvas on the rollout of this impressive program to benefit the cannabis industry here in Canada and abroad."

With city and provincial governments stating concerns regarding the legalization of cannabis and its potential impact on neighbourhood safety and public health, PUF has teamed up with Cannvas to take a proactive approach to solving these issues. Cannvas Marché will improve accessibility to free and unbiased education on deriving the potential benefits of medical and adult-use cannabis, while providing consumers with retail options from leading cannabis brands.

Cannvas is working with top regulators and compliance bodies to begin the first phase of creating a network of this first-of-its-kind public cannabis education and fulfillment centres.

The Company intends to expand the reach of its Cannvas Marché centres to communities across Canada through a licensing model and leverage its strategic partnerships to further integrate the Cannvas.Me platform into existing retail experiences.

Operating under the brand Cannvas Marché, each location will feature digital learning resources, on-site medical and educational staff and a fulfillment program. Hands-on education sessions on a variety of cannabis-related topics will also be featured, but without the usual pressure to purchase or consume. The sessions will be led by a registered health practitioner or certified educator and showcase original physician-backed content created for the Cannvas.Me platform. Visitors can register for free seminars each week or drop in anytime.The first location is expected to open in Toronto in 2019.

About Cannvas MedTech Inc.

Cannvas MedTech is a leading business technology company in the cannabis space. We design and build customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers.

About PUF Ventures Inc.

PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies including AAA Heidelberg and Propagation Services Canada in Canada, a large-scale greenhouse project in Australia and actively pursuing other opportunities within the cannabis industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., an advanced applicant for an ACMPR license. For more information please visit: www.puf.ca.

ON BEHALF OF THE BOARD OF DIRECTORS Derek IvanyPresident & CEO

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.

SOURCE PUF Ventures

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/October2018/16/c1382.html

SOURCE: PUF Ventures
PUF Ventures Inc., E: [e-mail], T: [phone]

Copyright (C) 2018 CNW Group. All rights reserved.

[grunt1]

PUF Ventures' Majority Owned Subsidiary Receives Cultivation License from Health Canada
15 Oct 2018 11:43 ET
CNW Group
PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), a growth oriented and diversified company focused on the international cannabis industry, is pleased to announce that its majority owned subsidiary, AAA Heidelberg Inc., has received its Access to Cannabis for Medical Purposes Regulations ("ACMPR") cultivation license from Health Canada. With this license, PUF Ventures is permitted to begin cultivating cannabis at its indoor facility located in London, Ontario.

"This is a very proud day for our Company and our loyal supporters alike," said Derek Ivany, President and CEO of PUF Ventures Inc. "Receiving a cultivation license from Health Canada is a significant achievement which positions PUF to become a leading cannabis supplier to legal medical and recreational markets, in Canada and around the world. As a partner of Canopy Growth Corporation's CraftGrow program, the Company looks forward to collaborating with CraftGrow to supply the marketplace with high quality cannabis. As we embark on this exciting next phase of growth, we are eager to expand our reach in both domestic and international cannabis markets."

With the receipt of the ACMPR cultivation license, AAA Heidelberg will begin preparing for the first crop of high-grade medical cannabis and PUF will move to immediately acquire the remaining ownership stake in the subsidiary.

In 2017, PUF partnered with Canopy Growth and joined its wholly-owned subsidiary, Tweed's CraftGrow program to sell the Company's medical cannabis. The CraftGrow program showcases the history, brand, and unique growing methods of each unique producer, with the goal of bringing select strains of high quality cannabis grown by a diverse set of producers to Tweed's registered customers. Through the partnership PUF's master grower will also work with Canopy's team to share expertise, technology, and best growing practices to maximize yield and ensure high quality product lines. PUF will also be able to source strains and lineage directly from Tweed's own breeding facility to add to its product line.

The granting of the ACMPR cultivation license from Health Canada follows announcements by PUF, on September 25 and October 11, 2018, regarding an equity participation and earn-in agreement with Delta Organic Cannabis Corp. ("DOCC"), a privately held Toronto-based cannabis investment company backed by pre- eminent leaders in Canadian cannabis enterprise. Pursuant to the agreement, DOCC may provide up to a $40-million investment at a price of $2.24 per PUF share for the development of a large-scale, commercial medical cannabis cultivation operation in Delta, B.C. The proceeds of the subscriptions are to be used exclusively to develop the Delta facility which currently consists of 2.2 million square feet of illuminated greenhouse space and 1.7 million square feet of ebb and flood irrigation space. It is currently anticipated that the first advance of funds by DOCC shall occur on October 17, 2018. Once the Delta Facility is permitted under the Cannabis Act, PUF Ventures will submit a second site cultivation license application for the facility.

About PUF Ventures Inc.

PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies including AAA Heidelberg and Propagation Services Canada in Canada, a large-scale greenhouse project in Australia and actively pursuing other opportunities within the cannabis industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., an advanced applicant for an ACMPR license. For more information please visit: www.puf.ca.

ON BEHALF OF THE BOARD OF DIRECTORS Derek IvanyPresident & CEO

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.

SOURCE PUF Ventures

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/October2018/15/c2854.html

SOURCE: PUF Ventures
PUF Ventures Inc., E: [e-mail], T: [phone]

Copyright (C) 2018 CNW Group. All rights reserved.

[grunt1]

IIROC Trading Halt - PVOT; PUF



Canada NewsWire

VANCOUVER, Oct. 15, 2018


VANCOUVER, Oct. 15, 2018 /CNW/ - The following issues have been halted by IIROC:

Company: Pivot Pharmaceuticals Inc.

CSE Symbol: PVOT

Reason: At the request of the Company Pending News

Halt Time (ET): 8:15 AM



Company: PUF Ventures Inc.

CSE Symbol: PUF

Reason: At the request of the Company Pending News

Halt Time (ET): 8:15 AM

IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Investment Industry Regulatory Organization of Canada (IIROC) - Halts/Resumptions


View original content: http://www.newswire.ca/en/releases/archive/October2018/15/c5927.html

IIROC Inquiries 1-877-442-4322 (Option 2) - Please note that IIROC is not able to provide any additional information regarding a specific trading halt. Information is limited to general enquiries only.Copyright CNW Group 2018

[grunt1]

PUF Ventures Provides Update to Equity Participation and Earn-In Agreement with Delta Organic Cannabis Corp.
11 Oct 2018 08:30 ET
CNW Group - CND
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES./

PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), an advanced Access to Cannabis for Medical Purposes Regulations ("ACMPR") license applicant, is pleased to provide an update to the previously announced Equity Participation and Earn-In Agreement (the "Agreement") with Delta Organic Cannabis Corp. ("DOCC"), a privately held Toronto-based cannabis investment company backed by preeminent leaders in Canadian cannabis enterprise, for up to a $40 million investment at a price of $2.24 per PUF share for the development of a large-scale, commercial medical cannabis cultivation operation in Delta, British Columbia.

PUF and DOCC have agreed to an extension to deadline for the first advance of funds by DOCC to PUF to October 17, 2018. As previously stated the completion of the transaction is subject to a number of conditions, including, but not limited to, completion of satisfactory due diligence, and the approval of the transaction by the Exchange, and the boards of directors of each of PUF and DOCC. Due to the size and complexity of the transaction, additional time is required to complete the transaction. All other terms of the contract do not change.

"We are working diligently to complete the transaction in a timely fashion," said Christopher MacIntyre, President of Delta Organic Cannabis Corp. "The scale and size of this project once converted will place us among a small but elite group of large-scale cannabis cultivation and propagation facilities."

"While PUF, DOCC and Propagation Services Canada are moving quickly to finalize the principal agreement, along with multiple ancillary and shareholder agreements relevant to this transaction, more time is necessary," said Derek Ivany, President and CEO of PUF Ventures. "We anticipate closing of the transaction by October 17, subject to Exchange and other approvals. The announcement of the transaction to fully fund the existing 2.2 million square foot greenhouse has generated significant inbound interest related to multiple important aspects of the go-forward business. The Delta Facility is poised to become one of the premier production sites for Canadian cannabis."

The proceeds of the subscriptions are to be used exclusively to develop the Delta propagation facility consisting of 2,200,000 square feet of illuminated greenhouse space and 1,700,000 square feet of "ebb and flood" irrigation space. This is an arm's length transaction and no finder's fees are to be paid.

About Delta Organic Cannabis Corp.

DOCC is Canadian focused vertically integrated cannabis company formed by some of the most successful early-movers in the space.

About PUF Ventures Inc.

PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies including AAA Heidelberg and Propagation Services Canada in Canada, a large-scale greenhouse project in Australia and actively pursuing other opportunities within the cannabis industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., an advanced applicant for an ACMPR license. For more information please visit: www.puf.ca.

ON BEHALF OF THE BOARD OF DIRECTORS

Derek Ivany President & CEO

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.

SOURCE PUF Ventures

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/October2018/11/c7703.html

SOURCE: PUF Ventures
PUF Ventures Inc., E: [e-mail], T: [phone]

Copyright (C) 2018 CNW Group. All rights reserved.

[grunt1]

PUF Ventures Congratulates Cannvas MedTech on the Launch of Cannvas.Me
09 Oct 2018 13:27 ET
CNW Group
PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), an advanced Access to Cannabis for Medical Purposes Regulations ("ACMPR") license applicant, is pleased to congratulate the team at Cannvas MedTech Inc. (CSE: MTEC) (Frankfurt: 3CM) for the launch of Cannvas.Me, an unbiased educational resource for medicinal and adult-use cannabis users which is now available online at http://Cannvas.Me.

In September 2017, PUF announced the spin-off of certain assets to form a company which subsequently became Cannvas MedTech.

"I would like to congratulate Shawn Moniz and Steve Loutskou of Cannvas MedTech on the launch of their first commercial online platform," said Derek Ivany, President and CEO of PUF Ventures. "We are on the eve of legalization and the cannabis space in Canada is in need of information and education that people can trust and rely on. Using advanced technology, Shawn and Steve have built an impressive web portal that delivers physician vetted content for both medicinal and recreational cannabis users. I wish Shawn and Steve and the rest of their team the very best on a successful launch and continued growth of their remarkable web portal."

Cannvas MedTech designs and builds customer-centric solutions that enable partners and clients to harness the power of data to truly understand their customers, industry, and key business drivers. The PUF spinout company has established itself as a leading business technology company in the cannabis health sciences space and began trading on the Canadian Stock Exchange with the symbol MTEC on July 3, 2018, and on the Frankfurt Exchange with the symbol 3CM on July 18, 2018.

Its first offering, Cannvas.Me, is a scalable, patient-centric life sciences learning platform for the global medical cannabis industry. Patients, consumers, medical practitioner and licensed producers, will use the Cannvas.Me platform for global interaction and cannabis education.

About Cannvas MedTech Inc.

Cannvas MedTech is a leading business technology company in the cannabis space. We design and build customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers. For additional information: www.cannvasmedtech.com.

About PUF Ventures Inc.

PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies including AAA Heidelberg and Propagation Services Canada in Canada, a large-scale greenhouse project in Australia and actively pursuing other opportunities within the cannabis industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., an advanced applicant for an ACMPR license. For more information please visit: www.puf.ca.

ON BEHALF OF THE BOARD OF DIRECTORS

Derek IvanyPresident & CEO

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.

SOURCE PUF Ventures

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/October2018/09/c3098.html

SOURCE: PUF Ventures
PUF Ventures Inc., E: [e-mail], T: [phone]

Copyright (C) 2018 CNW Group. All rights reserved.

[grunt1]

PUF Ventures Congratulates Cannvas MedTech on the Launch of Cannvas.Me
09 Oct 2018 13:27 ET
CNW Group
PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), an advanced Access to Cannabis for Medical Purposes Regulations ("ACMPR") license applicant, is pleased to congratulate the team at Cannvas MedTech Inc. (CSE: MTEC) (Frankfurt: 3CM) for the launch of Cannvas.Me, an unbiased educational resource for medicinal and adult-use cannabis users which is now available online at http://Cannvas.Me.

In September 2017, PUF announced the spin-off of certain assets to form a company which subsequently became Cannvas MedTech.

"I would like to congratulate Shawn Moniz and Steve Loutskou of Cannvas MedTech on the launch of their first commercial online platform," said Derek Ivany, President and CEO of PUF Ventures. "We are on the eve of legalization and the cannabis space in Canada is in need of information and education that people can trust and rely on. Using advanced technology, Shawn and Steve have built an impressive web portal that delivers physician vetted content for both medicinal and recreational cannabis users. I wish Shawn and Steve and the rest of their team the very best on a successful launch and continued growth of their remarkable web portal."

Cannvas MedTech designs and builds customer-centric solutions that enable partners and clients to harness the power of data to truly understand their customers, industry, and key business drivers. The PUF spinout company has established itself as a leading business technology company in the cannabis health sciences space and began trading on the Canadian Stock Exchange with the symbol MTEC on July 3, 2018, and on the Frankfurt Exchange with the symbol 3CM on July 18, 2018.

Its first offering, Cannvas.Me, is a scalable, patient-centric life sciences learning platform for the global medical cannabis industry. Patients, consumers, medical practitioner and licensed producers, will use the Cannvas.Me platform for global interaction and cannabis education.

About Cannvas MedTech Inc.

Cannvas MedTech is a leading business technology company in the cannabis space. We design and build customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers. For additional information: www.cannvasmedtech.com.

About PUF Ventures Inc.

PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies including AAA Heidelberg and Propagation Services Canada in Canada, a large-scale greenhouse project in Australia and actively pursuing other opportunities within the cannabis industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., an advanced applicant for an ACMPR license. For more information please visit: www.puf.ca.

ON BEHALF OF THE BOARD OF DIRECTORS

Derek IvanyPresident & CEO

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.

SOURCE PUF Ventures

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/October2018/09/c3098.html

SOURCE: PUF Ventures
PUF Ventures Inc., E: [e-mail], T: [phone]

Copyright (C) 2018 CNW Group. All rights reserved.

[grunt1]

Natures Hemp Formulates Hemp Based Coffee Creamer



Canada NewsWire

VANCOUVER, Oct. 2, 2018


Successful Trials by the University of Manitoba Lead to Healthy Alternative

VANCOUVER, Oct. 2, 2018 /CNW/ - PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), an advanced Access to Cannabis for Medical Purposes Regulations ("ACMPR") license applicant, is pleased to announce that Natures Hemp Corp. ("Natures Hemp"), a biotechnology and consumer products company focused on unlocking the true value of hemp for both B2B and B2C markets, has reported the successful formulation and initial test results of a hemp based coffee creamer by the Richardson Centre of Functional Foods and Nutraceuticals at the University of Manitoba.


PUF Ventures (CNW Group/PUF Ventures)

"Working with the University of Manitoba, Natures Hemp formulated an all-natural, hemp-based, non-dairy coffee creamer which tastes good and has all the characteristics of conventional creamers without the worrying ingredients," said Derek Ivany, President and CEO of PUF Ventures. "Coffee drinkers are looking for a healthy alternative to conventional coffee creamers and Natures Hemp all-natural coffee creamer comes with all the healthy benefits of cannabidiols including: healthy omega-3 and omega-6 fatty acids, iron, vitamin E, and essential amino acids."

Hemp is traditionally known for its use in textiles due its long and strong fibers, but hemp seeds have become the source of a robust health food and alternative medicinal marketplace. Hemp seeds are being recognized as a superfood, like flax and chia seeds, because they are high in protein, contain 20 amino acids, and are also high in the fatty acids omega-3 and omega-6. Seeds are typically pressed to produce oil and the remaining byproduct is processed into a flour from which products like pasta, baked goods and other healthy foods can be created. Nature Hemp's healthy alternative non-dairy coffee creamer is made using the whole seed with added water.

Cannabidiol (CBD) is the naturally occurring compound found in the seeds, stalk and flowers of hemp plants. Scientific and clinical research is ongoing but early indications show that CBD is a potential treatment for patients looking for relief from inflammation, pain, anxiety, psychosis, seizures, spasms, and other conditions. Potential health benefits from hemp food products include weight suppressant (high in fiber), immune-system booster, and an ability to lower blood pressure and cholesterol.

Natures Hemp is establishing a premium brand of quality CBD products, with an emphasis on health and wellness, in one of the fastest growing segments in the cannabis industry. The Company is focused at unlocking the true value of hemp by developing a new generation of plant-based, nutrient rich CBD food, beverage and healthcare related products.

About Natures Hemp Corp.

Nature Hemp is a biotechnology and consumer products company focused on unlocking the true value of hemp and developing a new generation of plant-based, nutrient rich cannabidiol (CBD) food, beverage and healthcare related products. It is establishing its own farms to produce high quality organic hemp plants and using a proprietary extraction technology to produce legal hemp fibers and CBD extract. It is also launching a premium brand of quality CBD products with an emphasis on health and wellness.

About PUF Ventures Inc.

PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies including AAA Heidelberg and Propagation Services Canada in Canada, a large-scale greenhouse project in Australia and actively pursuing other opportunities within the cannabis industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., an advanced applicant for an ACMPR license. For more information please visit: www.puf.ca.

ON BEHALF OF THE BOARD OF DIRECTORS

Derek Ivany
President & CEO

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.



SOURCE PUF Ventures


View original content to download multimedia: http://www.newswire.ca/en/releases/archive/October2018/02/c7042.html

PUF Ventures Inc., E: [e-mail], T: [phone]Copyright CNW Group 2018

[grunt1]

Natures Hemp Formulates Hemp Based Coffee Creamer



Canada NewsWire

VANCOUVER, Oct. 2, 2018


Successful Trials by the University of Manitoba Lead to Healthy Alternative

VANCOUVER, Oct. 2, 2018 /CNW/ - PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), an advanced Access to Cannabis for Medical Purposes Regulations ("ACMPR") license applicant, is pleased to announce that Natures Hemp Corp. ("Natures Hemp"), a biotechnology and consumer products company focused on unlocking the true value of hemp for both B2B and B2C markets, has reported the successful formulation and initial test results of a hemp based coffee creamer by the Richardson Centre of Functional Foods and Nutraceuticals at the University of Manitoba.


PUF Ventures (CNW Group/PUF Ventures)

"Working with the University of Manitoba, Natures Hemp formulated an all-natural, hemp-based, non-dairy coffee creamer which tastes good and has all the characteristics of conventional creamers without the worrying ingredients," said Derek Ivany, President and CEO of PUF Ventures. "Coffee drinkers are looking for a healthy alternative to conventional coffee creamers and Natures Hemp all-natural coffee creamer comes with all the healthy benefits of cannabidiols including: healthy omega-3 and omega-6 fatty acids, iron, vitamin E, and essential amino acids."

Hemp is traditionally known for its use in textiles due its long and strong fibers, but hemp seeds have become the source of a robust health food and alternative medicinal marketplace. Hemp seeds are being recognized as a superfood, like flax and chia seeds, because they are high in protein, contain 20 amino acids, and are also high in the fatty acids omega-3 and omega-6. Seeds are typically pressed to produce oil and the remaining byproduct is processed into a flour from which products like pasta, baked goods and other healthy foods can be created. Nature Hemp's healthy alternative non-dairy coffee creamer is made using the whole seed with added water.

Cannabidiol (CBD) is the naturally occurring compound found in the seeds, stalk and flowers of hemp plants. Scientific and clinical research is ongoing but early indications show that CBD is a potential treatment for patients looking for relief from inflammation, pain, anxiety, psychosis, seizures, spasms, and other conditions. Potential health benefits from hemp food products include weight suppressant (high in fiber), immune-system booster, and an ability to lower blood pressure and cholesterol.

Natures Hemp is establishing a premium brand of quality CBD products, with an emphasis on health and wellness, in one of the fastest growing segments in the cannabis industry. The Company is focused at unlocking the true value of hemp by developing a new generation of plant-based, nutrient rich CBD food, beverage and healthcare related products.

About Natures Hemp Corp.

Nature Hemp is a biotechnology and consumer products company focused on unlocking the true value of hemp and developing a new generation of plant-based, nutrient rich cannabidiol (CBD) food, beverage and healthcare related products. It is establishing its own farms to produce high quality organic hemp plants and using a proprietary extraction technology to produce legal hemp fibers and CBD extract. It is also launching a premium brand of quality CBD products with an emphasis on health and wellness.

About PUF Ventures Inc.

PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies including AAA Heidelberg and Propagation Services Canada in Canada, a large-scale greenhouse project in Australia and actively pursuing other opportunities within the cannabis industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., an advanced applicant for an ACMPR license. For more information please visit: www.puf.ca.

ON BEHALF OF THE BOARD OF DIRECTORS

Derek Ivany
President & CEO

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.



SOURCE PUF Ventures


View original content to download multimedia: http://www.newswire.ca/en/releases/archive/October2018/02/c7042.html

PUF Ventures Inc., E: [e-mail], T: [phone]Copyright CNW Group 2018

[grunt1]

PUF VENTURES INC (CA: PUF)








Last: 0.95 Change: 0.06 Volume: 489,154 Last Trade: 12:12



News Story



PUF Ventures Announces $40 Million Investment for Development of Large Scale Cannabis Cultivation Facility in Delta, B.C.
25 Sep 2018 15:42 ET
CNW Group
PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), an advanced Access to Cannabis for Medical Purposes Regulations ("ACMPR") license applicant, and Delta Organic Cannabis Corp. ("DOCC"), a privately held Toronto-based cannabis investment company backed by preeminent leaders in Canadian cannabis enterprise, today signed an Equity Participation and Earn-In Agreement (the "Agreement") which provides for up to $40 million in investment at a price of $2.24 per PUF share for the development of a large-scale, commercial medical cannabis cultivation operation in Delta, British Columbia. The proceeds of the subscriptions shall be used exclusively to develop the Delta propagation facility (the "Delta Facility") consisting of 2,200,000 sq. feet of illuminated greenhouse space and 1,700,000 sq. feet of "ebb and flood" irrigation space. This is an arm's length transaction and no finder's fees are to be paid.

Derek Ivany, President & CEO of PUF, commented: "On behalf of our entire team, I am extremely pleased to announce the achievement of this marquee milestone for PUF. We have constantly strived to deliver shareholder value and I believe this significant financial commitment in support of our state-of-the-art greenhouse project in British Columbia demonstrates the tremendous value of this endeavour. In comparison to other existing large-scale cannabis cultivation facilities, the finalization of this project catapults PUF into the upper echelon of participants in the space." Mr. Ivany continued, "This sizeable financial commitment will provide enough capital to allow us to focus the majority of our strategy on high quality cannabis flowering while also still advancing the propagation service aspect of our business thus creating a more diversified revenue mix."

Christopher MacIntyre, President of DOCC, stated: "PUF has secured one of the largest existing greenhouses in Canada. With over $75 million already invested into the Delta facility, advanced growing technologies, access to power, and incredible personnel, the retrofit to cannabis production and licensing is anticipated to be swift." He continued, "We are also very pleased to be entering this joint venture as a shareholder of PUF. The fact that we will be acquiring PUF equity at over $2 per share reflects the excellent and exciting suite of assets that the Company has assembled over the past year."

Equity Participation and Subscription

Pursuant to the Agreement, DOCC shall subscribe for and purchase up to 17,832,816 common shares in the capital of PUF (the "Common Shares") at a price of $2.24 per PUF share, representing 19.9% of the issued and outstanding Common Shares of PUF on a fully diluted basis, in consideration for aggregate subscription proceeds of $40,000,000, such proceeds payable on the following draw down schedule:
-- On or before October 8, 2018, DOCC shall advance $12,500,000 in
subscription proceeds in exchange for 5,572,755 Common Shares;
-- On or before November 15, 2018, DOCC shall advance $7,500,000
in subscription proceeds in exchange for 3,343,653 Common
Shares;
-- On or before November 30, 2018, DOCC shall advance $5,000,000
in subscription proceeds in exchange for 2,229,102 Common
Shares;
-- On or before January 15, 2019, DOCC shall advance $5,000,000 in
subscription proceeds in exchange for 2,229,102 Common Shares;
and
-- On or before March 1, 2019, DOCC shall advance $10,000,000 in
subscription proceeds in exchange for 4,458,204 Common Shares.




For greater certainty, at no time during the currency of the Agreement shall DOCC hold greater than 19.9% of the issued and outstanding common shares of PUF.

Earn-In Rights

In consideration of DOCC's equity investment, PUF shall grant to DOCC the right to earn up to 20% (the "Earn-In Right") of PUF's ownership interest in and to Propagation Services Canada Inc. ("PSC"), owner of the Delta Facility. The Earn-In Right shall be exercised according to the following earn-in schedule from PUF's current 50% portion of PSC:
-- DOCC shall earn 6.25% of PSC, by satisfaction of $12,500,000 of
the defined subscription obligation;
-- DOCC shall earn an additional 3.75% (for a total of 10%) of PSC
by satisfaction of a further $7,500,000 of the defined
subscription obligations;
-- DOCC shall earn an additional 2.5% (for a total of 12.5%) of
PSC by satisfaction of a further $5,000,000 of the defined
subscription obligations;
-- DOCC shall earn an additional 2.5% (for a total of 15%) of PSC
by satisfaction of a further $5,000,000 of the defined
subscription obligations; and
-- DOCC shall earn an additional 5.0% (for a total of 20%) of PSC
by satisfaction of a further $10,000,000 of the defined
subscription obligations.




The completion of the transaction as contemplated by the Agreement is subject to a number of conditions, including, but not limited to, completion of satisfactory due diligence, and the approval of the transaction by the Exchange, and the boards of directors of each of PUF and DOCC.

About PUF Ventures Inc.

PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies including AAA Heidelberg and Propagation Services Canada in Canada, a large-scale greenhouse project in Australia and actively pursuing other opportunities within the cannabis industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., an advanced applicant for an ACMPR license. For more information please visit: www.puf.ca.

About Delta Organic Cannabis Corp.

DOCC is Canadian focused vertically integrated cannabis company formed by some of the most successful early-movers in the space.

ON BEHALF OF THE BOARD OF DIRECTORS

Derek IvanyPresident & CEO

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.

SOURCE PUF Ventures

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/September2018/25/c4849.html

SOURCE: PUF Ventures
PUF Ventures Inc., E: [e-mail], T: [phone]

Copyright (C) 2018 CNW Group. All rights reserved.




Chart not available

































PUF VENTURES INC (CA: PUF)








Last: 0.95 Change: 0.06 Volume: 489,154 Last Trade: 12:12



News Story



PUF Ventures Announces $40 Million Investment for Development of Large Scale Cannabis Cultivation Facility in Delta, B.C.
25 Sep 2018 15:42 ET
CNW Group
PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), an advanced Access to Cannabis for Medical Purposes Regulations ("ACMPR") license applicant, and Delta Organic Cannabis Corp. ("DOCC"), a privately held Toronto-based cannabis investment company backed by preeminent leaders in Canadian cannabis enterprise, today signed an Equity Participation and Earn-In Agreement (the "Agreement") which provides for up to $40 million in investment at a price of $2.24 per PUF share for the development of a large-scale, commercial medical cannabis cultivation operation in Delta, British Columbia. The proceeds of the subscriptions shall be used exclusively to develop the Delta propagation facility (the "Delta Facility") consisting of 2,200,000 sq. feet of illuminated greenhouse space and 1,700,000 sq. feet of "ebb and flood" irrigation space. This is an arm's length transaction and no finder's fees are to be paid.

Derek Ivany, President & CEO of PUF, commented: "On behalf of our entire team, I am extremely pleased to announce the achievement of this marquee milestone for PUF. We have constantly strived to deliver shareholder value and I believe this significant financial commitment in support of our state-of-the-art greenhouse project in British Columbia demonstrates the tremendous value of this endeavour. In comparison to other existing large-scale cannabis cultivation facilities, the finalization of this project catapults PUF into the upper echelon of participants in the space." Mr. Ivany continued, "This sizeable financial commitment will provide enough capital to allow us to focus the majority of our strategy on high quality cannabis flowering while also still advancing the propagation service aspect of our business thus creating a more diversified revenue mix."

Christopher MacIntyre, President of DOCC, stated: "PUF has secured one of the largest existing greenhouses in Canada. With over $75 million already invested into the Delta facility, advanced growing technologies, access to power, and incredible personnel, the retrofit to cannabis production and licensing is anticipated to be swift." He continued, "We are also very pleased to be entering this joint venture as a shareholder of PUF. The fact that we will be acquiring PUF equity at over $2 per share reflects the excellent and exciting suite of assets that the Company has assembled over the past year."

Equity Participation and Subscription

Pursuant to the Agreement, DOCC shall subscribe for and purchase up to 17,832,816 common shares in the capital of PUF (the "Common Shares") at a price of $2.24 per PUF share, representing 19.9% of the issued and outstanding Common Shares of PUF on a fully diluted basis, in consideration for aggregate subscription proceeds of $40,000,000, such proceeds payable on the following draw down schedule:
-- On or before October 8, 2018, DOCC shall advance $12,500,000 in
subscription proceeds in exchange for 5,572,755 Common Shares;
-- On or before November 15, 2018, DOCC shall advance $7,500,000
in subscription proceeds in exchange for 3,343,653 Common
Shares;
-- On or before November 30, 2018, DOCC shall advance $5,000,000
in subscription proceeds in exchange for 2,229,102 Common
Shares;
-- On or before January 15, 2019, DOCC shall advance $5,000,000 in
subscription proceeds in exchange for 2,229,102 Common Shares;
and
-- On or before March 1, 2019, DOCC shall advance $10,000,000 in
subscription proceeds in exchange for 4,458,204 Common Shares.




For greater certainty, at no time during the currency of the Agreement shall DOCC hold greater than 19.9% of the issued and outstanding common shares of PUF.

Earn-In Rights

In consideration of DOCC's equity investment, PUF shall grant to DOCC the right to earn up to 20% (the "Earn-In Right") of PUF's ownership interest in and to Propagation Services Canada Inc. ("PSC"), owner of the Delta Facility. The Earn-In Right shall be exercised according to the following earn-in schedule from PUF's current 50% portion of PSC:
-- DOCC shall earn 6.25% of PSC, by satisfaction of $12,500,000 of
the defined subscription obligation;
-- DOCC shall earn an additional 3.75% (for a total of 10%) of PSC
by satisfaction of a further $7,500,000 of the defined
subscription obligations;
-- DOCC shall earn an additional 2.5% (for a total of 12.5%) of
PSC by satisfaction of a further $5,000,000 of the defined
subscription obligations;
-- DOCC shall earn an additional 2.5% (for a total of 15%) of PSC
by satisfaction of a further $5,000,000 of the defined
subscription obligations; and
-- DOCC shall earn an additional 5.0% (for a total of 20%) of PSC
by satisfaction of a further $10,000,000 of the defined
subscription obligations.




The completion of the transaction as contemplated by the Agreement is subject to a number of conditions, including, but not limited to, completion of satisfactory due diligence, and the approval of the transaction by the Exchange, and the boards of directors of each of PUF and DOCC.

About PUF Ventures Inc.

PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies including AAA Heidelberg and Propagation Services Canada in Canada, a large-scale greenhouse project in Australia and actively pursuing other opportunities within the cannabis industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., an advanced applicant for an ACMPR license. For more information please visit: www.puf.ca.

About Delta Organic Cannabis Corp.

DOCC is Canadian focused vertically integrated cannabis company formed by some of the most successful early-movers in the space.

ON BEHALF OF THE BOARD OF DIRECTORS

Derek IvanyPresident & CEO

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.

SOURCE PUF Ventures

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/September2018/25/c4849.html

SOURCE: PUF Ventures
PUF Ventures Inc., E: [e-mail], T: [phone]

Copyright (C) 2018 CNW Group. All rights reserved.

[grunt1]

PUF VENTURES INC (CA: PUF)








Last: 0.79 Change: 0.00 Volume: 0 Last Trade: 09/20



News Story



PUF Ventures and Liberty Leaf Holdings Execute MOU to Form Joint Venture to Explore Cannabis Cultivation in Greece
20 Sep 2018 17:43 ET
CNW Group
PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), an advanced Access to Cannabis for Medical Purposes Regulations ("ACMPR") license applicant, and Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (Frankfurt: HN3P), (together, "the Parties") a company in the business of acquiring partnership interests in up-and-coming and established companies in the medicinal and recreational cannabis sector, are pleased to announce the execution of a Memorandum of Understanding ("MOU") which outlines the basis whereby the Parties will undertake the formation of a joint venture partnership for the purposes of developing a medical cannabis project for the cultivation and sale of medical cannabis in Greece. The joint venture company is currently in discussions with potential local partners with suitable resources and expertise to participate in the development of a large-scale, medical cannabis commercial cultivation operation.

"I am impressed with the work accomplished by Derek and his team in the international cannabis markets," said Will Rascan, President and CEO of Liberty Leaf Holdings. "We are looking to leverage our respective capabilities, combined knowledge and experience to successfully develop a large-scale commercial medical cannabis project in Greece."

"Europe has been in our sights for quite some time and I am pleased to partner with Will and the Liberty Leaf team to pursue a cannabis project in Greece," said Derek Ivany, President and CEO of PUF Ventures. "PUF has developed a successful business model whereby we identify friendly cannabis jurisdictions, partner with local experts, engage governments and academia, and design and build large-scale, eco-friendly, commercial cannabis cultivation operations. We are pursuing large-scale greenhouse projects in Australia and in Canada, and we believe that we have assembled the team to successfully navigate challenging regulatory environments and build highly efficient, low cost cannabis production facilities in Greece. I look forward to working with Liberty Leaf and bringing the PUF brand and business model to the great country of Greece."

Cannabis has a long history in Greece with the earliest mention of use found in fifth century BC Greek texts. Today there is significant interest to invest in local cultivation projects due to a new legal framework for medicinal cannabis brought in by the Greek government in 2017.

With the Greek economy experiencing many recent years of financial crisis, both federal and state government bodies are motivated to aid investment projects that can boost the economy and bring local employment. Furthermore, the relatively low cost for real estate and labour combined with regions of fertile land and warm dry climates, similar to California, there is an opportunity to produce low cost, high quality cannabis on a large-scale commercial basis.

Greece is also a natural gateway to the European Union, which is home to more than 500 million people, a population that is significantly larger than the population of the United States and Canada--the two largest cannabis markets in the world today.

The Parties will provide additional updates on joint venture formation, structure and business development in due course.

About Liberty Leaf

Liberty Leaf Holdings Ltd. is a Canadian-based, public company whose focus is to build and support a diversified portfolio of cannabis-sector businesses, including cultivation, processing, value-added CBD/THC pet products and supply-chain products within this dynamic and fast-growing sector.

Liberty Leaf's late-stage ACMPR portfolio consists of a 60% interest in Just Kush and 100% of North Road Ventures. The company has launched its Signature Cannabis Retail division, an enterprise that is expected to roll out across Canada, bringing recreational cannabis to market for consumers. For further info on the Company please visit http://www.libleaf.com or email [e-mail].

About PUF Ventures Inc.

PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies including AAA Heidelberg and Propagation Services Canada and is actively pursuing other opportunities within the cannabis industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., an advanced applicant for an ACMPR license. For more information please visit: www.puf.ca.

ON BEHALF OF THE BOARD OF DIRECTORS

Derek IvanyPresident & CEO

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.

SOURCE PUF Ventures

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/September2018/20/c2257.html

SOURCE: PUF Ventures
PUF Ventures Inc., E: [e-mail], T: [phone]

Copyright (C) 2018 CNW Group. All rights reserved.

[grunt1]

PUF VENTURES INC (CA: PUF)








Last: 0.69 Change: -0.01 Volume: 70,499 Last Trade: 10:15



News Story



PUF Ventures Perfectly Positioned to Benefit from a Renewed Enthusiasm in the Canadian Cannabis Space
14 Sep 2018 16:17 ET
GlobeNewswire
Enthusiasm has returned to the legal cannabis space in Canada and PUF Ventures Inc. (CSE: PUF) (OTC: PUFXF), a late stage ACMPR license candidate, appears to be in perfect position to take advantage of the public's renewed interest. PUF has a proven track record of creating shareholder value through the pursuance of niche market opportunities, and in burgeoning sectors, such as the legal cannabis industry, niche market opportunities remain both innumerous and profitable. The rekindled enthusiasm in the space will begin to drive these niche markets, especially as the effective date of legalization (October 17, 2018) draws nearer, and PUF will be one of the few organizations already engaged in the unique and untapped market opportunities that currently exist.

Causes for Enthusiasm

Several events have signalled the return of enthusiasm to the legal cannabis market in Canada. Investors have been once again rallying behind the most popular companies in the space, causing the price of the Canadian Marijuana Index to increase nearly 100% in the last month. Continued regulatory reform has also increased confidence in the industry as Health Canada has made significant strides in the last two months, loosening the restrictions on hemp plant use. Finally, the Canadian cannabis market is starting to receive substantial investment from powerful international entities. Constellation Brands, probably best known in Canada for producing Corona, recently decided to invest an additional $5 billion into cannabis bellwether, Canopy Growth Corp. When Fortune 500 companies such as Constellation begin pouring billions of dollars into a burgeoning market, you can be certain that there is both spirited interest and immeasurable potential.

Identification of Emerging Trends and Track Record of Value Creation for Shareholders

The team at PUF Ventures has proven time and time again that they are exceptionally skilled at identifying emerging trends and harnessing them in a manner that creates considerable value for their shareholders. Late last year, PUF initiated a spin-out of its wholly owned subsidiary Cannvas Medtech, a leading business technology company within the health sciences space, and provided PUF shareholders with one MTEC share for every seven shares of PUF that they already owned. MTEC is now publicly traded as a stand-alone company and, as of the date of this release, possesses a market cap of more than $14 million and a share price of $0.38.

PUF has also expanded their pursuance of niche and emerging trends to markets outside of Canada. In 2017, PUF purchased a sizeable ownership stake in Solaris Nutraceuticals Pty. Ltd. Solaris Nutraceuticals is building a 1.2 million square foot greenhouse operation on a 27-hectare parcel of land near the town of Casino in northern New South Wales, Australia. When complete, the greenhouse will be one of the most technically advanced and environmentally sustainable medical cannabis operations in the world. It will include large-scale greenhouse, manufacturing, processing and office facilities for the cultivation, production and manufacture of medical cannabis and associated products in Australia. The first phase of the project will cover approximately 300,000 square feet, making it the largest medical cannabis greenhouse in Australia.

In recent months, PUF has also initiated another spin-out with its subsidiary Nature's Hemp, a biotechnology and consumer products company focused on unlocking the true value of hemp for both B2B and B2C markets. The Nature's Hemp spin-out will provide PUF shareholders with one share of Nature's Hemp for every 3.3665 shares of PUF owned as of June 18th, 2018.

Looking Ahead - Potential Cultivation Expansion

This past summer PUF secured a highly enviable potential expansion opportunity for large scale cannabis cultivation. PUF solidified a deal, via a 50/50 joint venture, granting them an exclusive 15-year license to a state of the art 2.2 million square foot greenhouse facility in Delta, BC. Further to the securement of this facility license, PUF also engaged industry consultants, Cannabis Compliance Inc., to aid them in preparing for the necessary regulatory-driven upgrades that the facility will need to undergo in order for large scale industrial cannabis cultivation to begin. This is a crucial component of the new endeavour as it means that PUF is well prepared to begin operations if, and when, they are awarded an ACMPR license.

This expansion potential grants PUF near term access to a facility that would otherwise take years and upwards of $100 million to build. In a market that is rapidly growing and evolving, this mechanism for cultivation expansion could indeed prove fruitful.

It is clear that PUF is in prime position to take advantage of the public's renewed enthusiasm in the cannabis space. They are continually seeking out new niche market opportunities and, while doing so, consistently creating value for their shareholders.

About PUF Ventures

PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies: AAA Heidelberg, Solaris Nutraceuticals Pty Ltd., and Natures Hemp Corp., and is actively pursuing other opportunities within the industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., a private Ontario company and advanced applicant for an ACMPR license. Solaris Nutraceuticals is building the largest medical cannabis greenhouse in the Southern Hemisphere. For more information please visit: www.puf.ca.

ON BEHALF OF THE BOARD OF DIRECTORS

Derek Ivany, President & CEO

For additional information:

PUF Ventures Inc.

E: [e-mail]

T: [phone]

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release. Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.

Global Objective Marketing

Do you want the same kind of exposure that PUF Ventures Inc. is receiving here? Contact Global Objective Marketing and we will produce professionally written press release content for your business and distribute it to any market that you wish to reach. For more information, please visit https://www.globalobjectivemarketing.com/.

This piece was written and distributed by Global Objective Marketing (GOM). All of the information contained within was produced using publicly available information and any opinions about individuals, companies or industries expressed within this release belong solely to GOM. The opinions expressed by GOM should not be considered as complete, accurate, or current investment advice. Any investment decisions made by readers are theirs and theirs alone. To ensure that you are making investment decisions that serve your own best interests, we recommend that you utilize the services of a professional financial planner or advisor. In order to comply with Section 17(b) of the 1933 Securities Act, GOM discloses that it was paid a sum of two thousand dollars CAD to write this content for PUF Ventures.

https://resource.globenewswire.com/media/c8e0be03-ec6d-466a-a781-46c54813a917/small/puf-ventures-logo-jpg.jpg

<img src="http://www.globenewswire.com/newsroom/ti?ndecode=MTUwIzczNzc5Mzk="; alt="" width="1" height="1"/>
(C) Copyright 2018 GlobeNewswire, Inc. All rights reserved.

[grunt1]

PUF VENTURES INC (CA: PUF)








Last: 0.69 Change: -0.01 Volume: 65,764 Last Trade: 10:14



News Story



PUF Ventures Announces Greenhouse Project Update and Proposed Issuance of Shares
14 Sep 2018 14:40 ET
CNW Group
PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), announces that the Company is proceeding with the 2.2 million square foot greenhouse project located in Delta, British Columbia (the "Project") which was announced on June 29, 2018. The Company has been in discussions with potential financiers regarding financing of the Project, is in the process of finalizing sublease, management and shareholder agreements related to the Project, and has completed several site tours of the facility.

In conjunction with the Project, the Company plans to issue up to 4,000,000 common shares of the Company (the "Shares") for services to key personnel including related parties assisting with the Project. The Shares will be issued in tranches, with up to 2,000,000 Shares to be issued next week and up to 2,000,000 Shares to be issued on execution of the outstanding agreements related to the Project. The deemed value of the Shares will be determined by the closing market price on the day preceding the issuance of the Shares.

Additionally, the Company has paid a $1,500,000 deposit on the Project and has spent an additional $200,000 for the hiring of security personnel for the property.

The Company is also in discussions with various tissue culture experts and have shortlisted certain experts for potential partnerships.

About the Company

PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies: AAA Heidelberg and Solaris Nutraceuticals Pty Ltd., and is actively pursuing other opportunities within the industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., a private Ontario company and advanced applicant for an ACMPR license. Solaris Nutraceuticals is building one of the largest medical cannabis greenhouses. For more information please visit: www.puf.ca.

ON BEHALF OF THE BOARD OF DIRECTORS

Derek IvanyPresident & CEO

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.

SOURCE PUF Ventures

View original content to download multimedia: http://www.newswire.ca/en/releases/archive/September2018/14/c8561.html

SOURCE: PUF Ventures
PUF Ventures Inc., E: [e-mail], T: [phone]

Copyright (C) 2018 CNW Group. All rights reserved.

[grunt1]

PUF Ventures Announces Closing of Plan of Arrangement With Natures Hemp Corp.



Canada NewsWire

VANCOUVER, Aug. 28, 2018


VANCOUVER, Aug. 28, 2018 /CNW/ - PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), and Natures Hemp Corp. ("Natures Hemp") are pleased to announce that effective August 28, 2018 (the "Effective Date"), they completed a statutory arrangement under a plan of arrangement (the "Arrangement"). As a result of completing the Arrangement, Natures Hemp became a reporting issuer in the provinces of British Columbia, Alberta and Ontario.


PUF Ventures (CNW Group/PUF Ventures)

Completion of the Arrangement, as set forth in the arrangement agreement and plan of arrangement dated May 18, 2018 (the "Arrangement Agreement"), between PUF and Natures Hemp Corp. was approved by the shareholders of PUF on August 7, 2018 and by a Final Order granted by the Supreme Court of British Columbia on August 13, 2018, in accordance with Part 9 of the Business Corporations Act (British Columbia).

Natures Hemp Corp.:

Pursuant to the Arrangement Agreement and on the Effective Date, the following occurred:



(a)

PUF distributed 100% of the common shares of Natures Hemp ("Natures Hemp Shares") it received to the shareholders of PUF (the "PUF Shareholders") on a pro rata basis. The PUF Shareholders received one Natures Hemp Share in exchange for every 3.3665 common shares of PUF held as at the Record Date, June 18, 2018;





(b)

PUF transferred the assets to Natures Hemp;





(c)

Natures Hemp became a reporting issuer in the Provinces of British Columbia, Alberta and Ontario;





(d)

PUF retained its working capital for its assets, remains listed on the CSE and will continue to trade under the trading symbol, PUF, as a consumer products – biotechnology/pharmaceuticals company; and





(e)

Natures Hemp completed the conversion of 11,666,000 special warrants into Natures Hemp Shares.




The CUSIP number for the common shares of Natures Hemp is 639021104.

As of the Effective Date, the board of directors of Natures Hemp are Derek Ivany, David Parry and Robert V. Matthews and the officers of Natures Hemp are Derek Ivany, CEO and Sean McGrath, CFO.

About the Company

PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies: AAA Heidelberg, Solaris Nutraceuticals Pty Ltd., and Natures Hemp Corp., and is actively pursuing other opportunities within the industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., a private Ontario company and advanced applicant for an ACMPR license. Solaris Nutraceuticals is building the largest medical cannabis greenhouse in the Southern Hemisphere. For more information please visit: www.puf.ca.

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of the release.

Some of the statements contained in the release are forward-looking statements, such as estimates and statements that describe the Company's future plans, objectives or goals, including words to the effect that the Company or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.



SOURCE PUF Ventures


View original content with multimedia: http://www.newswire.ca/en/releases/archive/August2018/28/c4206.html

regarding PUF Ventures Inc. or Natures Hemp Corp. please contact: Derek Ivany, President & CEO; For additional information: PUF Ventures Inc., E: [e-mail], T: [phone]Copyright CNW Group 2018

[grunt1]

News Story



PUF Ventures and Natures Hemp Applaud Health Canada Changes to Industrial Hemp Regulations
15 Aug 2018 16:13 ET
CNW Group
PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), an advanced Access to Cannabis for Medical Purposes Regulations ("ACMPR") license applicant, and Natures Hemp Corp., a biotechnology and consumer products company focused on unlocking the true value of the hemp for both B2B and B2C markets, commend Health Canada for the recent changes to Industrial Hemp Regulations and specifically the publication of the Subsection 56(1) Class Exemption in relation to the use of hemp under industrial hemp regulations (flowering heads, leaves and branches).

"Natures Hemp is developing nutrient rich cannabidiol (CBD) food, beverage and healthcare related products and we support any move to lessen the restrictions surrounding industrial hemp production," said Derek Ivany, President and CEO of PUF Ventures Inc. "With the legalization of cannabis in Canada on October 17, 2018, the changes are timely to allow hemp cultivators use the whole plant with their next harvest. It allows for the extraction of CBD from hemp to start immediately and provides a new revenue source for industrial hemp producers. We applaud Health Canada for this exemption to the industrial hemp regulations and the work they do for the cannabis industry."

The Health Canada exemption published by on August 10, 2018, allows licensed industrial hemp cultivator companies to begin to use the whole hemp plant for commercial purposes. Historically, cultivators were required to discard flowering heads, leaves and branches. Under the new exemption effective August 10, 2018, cultivators can harvest, dry, and store industrial hemp flowers, leaves, branches and other waste materials that contain valuable CBD content which can be used to produce food, beverage and other health related products.

About Natures Hemp Corp.

Nature Hemp is a biotechnology and consumer products company focused on unlocking the true value of hemp and developing a new generation of plant-based, nutrient rich cannabidiol (CBD) food, beverage and healthcare related products. It is establishing its own farms to produce high quality organic hemp plants and using a proprietary extraction technology to produce legal hemp fibers and CBD extract. It is also launching a premium brand of quality CBD products with an emphasis on health and wellness. 2 Currently. Natures Hemp is a subsidiary of PUF. Pursuant to the previously announced plan of arrangement between Natures Hemp and PUF, if the plan of arrangement is approved by the shareholders of PUF and the court, it is expected that Natures Hemp will become a reporting issuer.

About PUF Ventures Inc.

PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies: AAA Heidelberg, Solaris Nutraceuticals Pty Ltd., and Natures Hemp Corp., and is actively pursuing other opportunities within the industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., a private Ontario company and advanced applicant for an ACMPR license. Solaris Nutraceuticals is building the largest medical cannabis greenhouse in the Southern Hemisphere. For more information please visit: www.puf.ca.

ON BEHALF OF THE BOARD OF DIRECTORS

Derek Ivany, President & CEO

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.

SOURCE PUF Ventures

View original content with multimedia: http://www.newswire.ca/en/releases/archive/August2018/15/c4914.html

SOURCE: PUF Ventures
PUF Ventures Inc., E: [e-mail], T: [phone]

Copyright (C) 2018 CNW Group. All rights reserved.

[grunt1]

PUF Ventures Announces the Court Approval of the Plan of Arrangement and Closing of First Tranche of $0.25 Special Warrant Private Placement
14 Aug 2018 16:15 ET
CNW Group
PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), is pleased to announce that on August 13, 2018, the Supreme Court of British Columbia approved the plan of arrangement among PUF, Natures Hemp Corp. ("Natures Hemp") and the shareholders of PUF (the "Arrangement"). The Company will proceed to complete the Arrangement, which includes the issuance of shares to the PUF shareholders of record as of June 18, 2018, on the basis of one new common share in Natures Hemp for every 3.3665 PUF shares held on a pro rata basis. Natures Hemp will issue approximately 17,500,000 common shares of Natures Hemp to the PUF shareholders. The Company received shareholder approval to the Arrangement at the Company's special meeting held on August 7, 2018.

For more information about the Arrangement please see the information circular of the Company dated June 18, 2018 and subsequent news releases dated August 3, 2018 and August 8, 2018 available on www.sedar.com.

The Company also announces that Natures Hemp has closed the first tranche of its special warrant financing at a price of $0.25 per special warrant through the issuance of 1,676,000 special warrants for aggregate gross proceeds of $419,000. Each special warrant is convertible into common shares of Natures Hemp.

About the Company

PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies: AAA Heidelberg, Solaris Nutraceuticals Pty Ltd., and Natures Hemp Corp., and is actively pursuing other opportunities within the industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., a private Ontario company and advanced applicant for an ACMPR license. Solaris Nutraceuticals is building the largest medical cannabis greenhouse in the Southern Hemisphere. For more information please visit: www.puf.ca.

ON BEHALF OF THE BOARD OF DIRECTORS

Derek Ivany, President & CEO

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.

SOURCE PUF Ventures

View original content with multimedia: http://www.newswire.ca/en/releases/archive/August2018/14/c5815.html

SOURCE: PUF Ventures
PUF Ventures Inc., E: [e-mail], T: [phone]

Copyright (C) 2018 CNW Group. All rights reserved.

[grunt1]

PUF Ventures Reports Special Meeting Results



Canada NewsWire

VANCOUVER, Aug. 8, 2018


VANCOUVER, Aug. 8, 2018 /CNW/ - PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), is pleased to announce the voting results of its Special Meeting held on August 7, 2018. A total of 10,492,782 common shares representing 17.81% of the issued shares of the Company were represented at the Meeting. All resolutions presented to the shareholders were approved (see the SEDAR filing of the Company's Information Circular dated June 18, 2018).


PUF Ventures (CNW Group/PUF Ventures)

Shareholders voted 98.4% in favour of the plan of arrangement, which involves the distribution of common shares of Natures Hemp Corp. ("Natures Hemp") to the shareholders of the Company and 98.3% in favour of the adoption of a 10% rolling stock option plan of Natures Hemp.

About PUF Ventures Inc.

PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies: AAA Heidelberg, Solaris Nutraceuticals Pty Ltd., and Natures Hemp Corp., and is actively pursuing other opportunities within the industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., a private Ontario company and advanced applicant for an ACMPR license. Solaris Nutraceuticals is building the largest medical cannabis greenhouse in the Southern Hemisphere. For more information please visit: www.puf.ca.

ON BEHALF OF THE BOARD OF DIRECTORS

Derek Ivany, President & CEO

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.



SOURCE PUF Ventures


View original content with multimedia: http://www.newswire.ca/en/releases/archive/August2018/08/c2758.html

PUF Ventures Inc., E: [e-mail], T: [phone]Copyright CNW Group 2018

[grunt1]

PUF Ventures Bringing Science of Plant Propagation to Medical and Recreational Cannabis Industry
31 Jul 2018 08:30 ET
GlobeNewswire
In an effort to differentiate itself from the emerging cannabis market in Canada, PUF Ventures Inc. (OTCPK: PUFXF) (CSE: PUF) (Frankfurt: PU3) has taken a novel approach to producing cannabis that should prove to be every bit as lucrative as growing it. With the idea of separating itself from the competition, the innovative Vancouver-based company partnered with Casey Houweling, who has 4 decades of experience with plant propagation, to form Propagation Services Canada Inc. (PSC), to introduce the concept of science-based vegetative propagation to the cannabis industry in Canada.

With the federal government in Canada passing Bill C-45 or the "Cannabis Act" and recreational cannabis becoming legal on October 17, 2018, the cannabis market in Canada has become an economic juggernaut. PUF Ventures will use its third party propagation services to navigate the landscape there and develop what should be an operation with long-term success in the industry.

While new to the cannabis industry, large-scale scientific vegetative propagation is commonplace in other plant markets like the tea industry and with many types of vegetables. The greatest benefit to using third party vegetative propagation in the cannabis industry is that it allows licensed producers the opportunity to use valuable floor space for growing revenue-generating flowering plants.

According to the analysis conducted by PUF while the company was reviewing opportunities within the Canadian cannabis industry, it learned that approximately 20 to 30 percent of a licensed producer's greenhouse is dedicated to cannabis propagation. If this area could be repurposed to grow flowering plants, licensed producers could, in turn, realize a similar increase in revenue.

Another advantage of vegetative propagation is that the new propagated plants contain the same genetic material and are essentially clones of the parent plant. Once the strain has been established with desired traits, it can be reproduced indefinitely. This is important when maintaining consistent quality and taste in products made from plants or crops such as teas, coffee, fruits and vegetables.

Propagation becomes especially important for commercial cannabis growers who want to reproduce the highest-quality cannabis with consistent strain genetics.

Large-scale cannabis propagation has become a reality in Canada due in large part to the efforts of Derek Ivany, President and CEO of PUF Ventures, and Casey Houweling, President of the Houweling's Group. The unlikely partnership comes from Ivany's quest to become a top-five licensed producer in Canada and Houweling's desire to leverage his 40 years of plant propagation experience, and a 2.2 million square-foot facility in Delta, British Columbia. The Delta facility is considered one of the most technologically advanced greenhouses in North America, offering full propagation services with an experienced staff in a facility with 18 megawatts of power.

"Over time I believe that cannabis will become a commodity with the price per gram dropping to levels close to the cost of production," said Derek Ivany. He continued by saying, "After a thorough analysis of the industry indicated that outsourcing plant propagation could bring significant benefits to the many licensed producers operating in Canada, we approached Casey Houweling to talk about a partnership. By specializing in an ancillary product, like propagation services, we can ensure that PUF's long-term revenue stream is optimized by offering high margin scientific expertise and high-quality products to the overall market."

By leveraging Casey Houweling's experience in plant propagation, PSC can ensure high quality clones without disease and contaminates and offer starter plants to the industry's growers that can help mitigate these challenges and focus on growing and processing flowering plants.

Experts agree.

PUF Ventures hired Cannabis Compliance Inc. to help it prepare the new commercial propagation facility in Delta, British Columbia. Cannabis Compliance is a cannabis consulting firm with more than 10 years experience providing risk mitigation, due diligence and regulatory compliance to commercial cannabis producers and resellers worldwide.

Nico Hache, Director of Compliance at Cannabis Compliance Inc., said of PSC's operations and its large-scale facility in British Columbia, "The combination of one of the most technically advanced greenhouse sites entering the cannabis industry and more than 40 years of propagation experience, is precisely what the cannabis industry requires to deliver clean, pure stock plants. The nursery plant mortality rate in the industry is very high due to the lack of facility and technical expertise to grow at scale. PSC has a facility, the technical expertise, and with a few modifications will change the way cannabis is grown. This expertise is what has been missing in the industry and will be welcomed by licensed producers."

PUF Ventures' Ivany added, "I believe that independent propagation services in the Canadian cannabis space will massively disrupt cannabis growing methods in a very positive way."

The value proposition that PSC brings to the licensed producers in the market is the specialized science of plant propagation, offering healthy flowering cannabis plants free of contaminates, pests and disease, less staffing requirements, and more greenhouse space to grow revenue-generating flowering plants--providing licensed producers with an advantage to optimize operations, reduce costs, increase revenue and ensure their long-term success in the industry.

In part 2 of our series highlighting PUF Ventures and its efforts to become part of the cannabis landscape in Canada, we'll focus on the benefits and economics of propagation and how PUF Ventures can improve topline revenue and bottom-line expenses for licensed producers.

Learn more about PUF Ventures and PSC at: www.puf.ca

About Stock Market Media Group

Stock Market Media Group is a Content Development IR firm offering a platform for corporate stories to unfold in the media with research reports, corporate videos, radio-style CEO interviews and feature news articles.

This article was written based upon publicly available information. Stock Market Media Group may from time to time include our own opinions about the companies, their business, markets and opportunities in our articles. Any opinions we may offer about any of the companies we write about are solely our own, and are made in reliance upon our rights under the First Amendment to the U.S. Constitution, and are provided solely for the general opinionated discussion of our readers. Our opinions should not be considered to be complete, precise, accurate, or current investment advice, or construed or interpreted as research. Any investment decisions you may make concerning any of the securities we write about are solely your responsibility based on your own due diligence. Our publications are provided only as an informational aid, and as a starting point for doing additional independent research. We encourage you to invest carefully and read the investor information available at the web site of the U.S. Securities and Exchange Commission at: www.sec.gov. We also recommend, as a general rule, that before investing in any securities you consult with a professional financial planner or advisor, and you should conduct a complete and independent investigation before investing in any security after prudent consideration of all pertinent risks. We are not a registered broker, dealer, analyst, or adviser. We hold no investment licenses and may not sell, offer to sell or offer to buy any security. Our publications about any of the companies we highlight in our content are not a recommendation to buy or sell a security. Section 17(b) of the 1933 Securities and Exchange Act requires publishers who distribute information about publicly traded securities for compensation, to disclose who paid them, the amount, and the type of payment. In order to be in full compliance with the Securities Act of 1933, Section 17(b), we are disclosing that we were paid one thousand dollars from a third party via bank wire to produce content related to PUF Ventures.

For more information: www.stockmarketmediagroup.com.

Contact:

Stock Market Media Group

[e-mail]
Contact:

Stock Market Media Group

[e-mail]


https://resource.globenewswire.com/Resource/Download/74ad44f1-a584-4c98-a5fd-a5997fc8a954?size=1

<img src="http://www.globenewswire.com/newsroom/ti?ndecode=MTUwIzczMzQzODk="; alt="" width="1" height="1"/>
(C) Copyright 2018 GlobeNewswire, Inc. All rights reserved.

[grunt1]

PUF Ventures Provides Update Regarding the Business of Natures Hemp Corp.



Canada NewsWire

VANCOUVER, July 18, 2018


VANCOUVER, July 18, 2018 /CNW/ - PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), an advanced Access to Cannabis for Medical Purposes Regulations ("ACMPR") license applicant, is pleased to provide an update on the business of its subsidiary Natures Hemp Corp. ("Natures Hemp").


PUF Ventures (CNW Group/PUF Ventures)

Natures Hemp, a biotechnology and consumer products company focused on unlocking the true value of the hemp for both B2B and B2C markets, and Cannvas MedTech Inc. ("Cannvas"), a leading business technology company within the cannabis space, are pleased to announce the signing of a letter of intent (the "LOI"), to negotiate in good faith a data analytics agreement, for which Cannvas will provide industry insight and analytical modelling capabilities to Natures Hemp business models and Key Performance Indicators (KPIs).

"As we work to complete the plan of arrangement with Natures Hemp, it continues to make strides to become a leading biotechnology and consumer products company," said Derek Ivany, President and CEO, of PUF Ventures. "It is currently working with the University of Manitoba to develop proprietary an organic hemp-based milk which contains no sugar and no cholesterol, is free of soy and gluten and is an abundant source of vital nutrients. The recent letter of intent between Natures Hemp and Cannvas could lead to an agreement and provide valuable market data and analytics to Natures Hemp as it looks to introduce new and exciting hemp-based products. I am very pleased that the two PUF spin-out companies are working together to create shareholder value."

Under the terms of the LOI, Cannvas will develop specific parameters within its existing Cannvas Data framework to collect data and analytics from Natures Hemp and their strategic partnerships, and Natures Hemp is expected to gain access to a broad data set as they press forward in the hemp sector and becomes a stand-alone public company. It is expected that the LOI and a subsequent agreement will allow Natures Hemp to bring the right products to market at the right time and to the right individuals, and will maximize Natures Hemp customer conversion funnel.

Cannvas Data is the analytics branch of Cannvas MedTech. Its mission is to collect data from various credible sources to enhance user personal data algorithms for Cannvas.me. Cannvas Data is expected to leverage existing databases, site traffic and advanced technology for marketing purposes, and is expected to leverage its comprehensive solution for the global hemp community. Cannvas and Natures Hemp have agreed to a discovery period whereby the technological specifications of the connectivity will be setup by Cannvas Data. Cannvas and Natures Hemp will work together towards a definitive partnership agreement within the next 45 days.

About Natures Hemp Corp.

Natures Hemp is a biotechnology and consumer products company focused on unlocking the true value of hemp and developing a new generation of plant-based, nutrient rich cannabidiol (CBD) food, beverage and healthcare related products. It is establishing its own farms to produce high quality organic hemp plants and using a proprietary extraction technology to produce legal hemp fibers and CBD extract. It is also launching a premium brand of quality CBD products with an emphasis on health and wellness. Currently. Natures Hemp is a subsidiary of PUF. Pursuant to the previously announced plan of arrangement between Natures Hemp and PUF, if the plan of arrangement is approved by the shareholders of PUF and the court, it is expected that Natures Hemp will become a reporting issuer.

About Cannvas MedTech Inc.

Cannvas MedTech is a leading business technology company within the cannabis space. We design and build customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers.

About PUF Ventures Inc.

PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies: AAA Heidelberg, Solaris Nutraceuticals Pty Ltd., and Natures Hemp Corp., and is actively pursuing other opportunities within the industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., an advanced applicant for an ACMPR license. Solaris Nutraceuticals is building the largest medical cannabis greenhouse in the Southern Hemisphere. For more information please visit: www.puf.ca.

ON BEHALF OF THE BOARD OF DIRECTORS

Derek Ivany
President & CEO

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.



SOURCE PUF Ventures

[grunt1]

News Story



PUF Ventures Engages Cannabis Compliance Inc. for Large-scale Greenhouse Facility in Delta, BC
05 Jul 2018 08:30 ET
CNW Group
PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), an advanced Access to Cannabis for Medical Purposes Regulations ("ACMPR") license applicant, is pleased to announce that it has engaged Cannabis Compliance Inc. (CCI) to prepare the new Propagation Canada Services (PSC) cannabis propagation facility in Delta, BC. CCI has more than 10 years experience providing risk mitigation, due diligence and regulatory compliance to commercial cannabis producers and resellers worldwide.

"We are very pleased to be working with the team at PUF, the Houwelings Group and the recently formed Propagation Services Canada, as they introduce large-scale propagation services to the cannabis sector," said Deepak Anand, Vice President of Business Development & Government Relations at Cannabis Compliance Inc. "This is one of the larger facilities that CCI has had the pleasure to work on and provide our regulatory expertise in preparation for Health Canada review. We have many clients who could benefit from this new propagation service to significantly increase revenue, protect intellectual property, reduce plant mortality and have a cleaner, safer and purer product for consumers."

"I believe that an independent propagation services in the Canadian cannabis space, will massively disrupt cannabis growing methods in a very positive way," said Derek Ivany, president and CEO of PUF Ventures. "Plant propagation is a scientific proposition requiring high tech labs and facilities, knowledgeable technicians and complex procedures to operate a successful operation. We are currently working with Casey to upgrade the existing greenhouses whereby PSC will supply flower-ready plants to growers and licensed producer and eliminate most of the technical risk of growing cannabis."

As previously announced Propagation Services Canada was recently formed by PUF Ventures and Casey Houweling, a vegetable greenhouse grower with over 40 years of propagation growing experience. Houweling currently operates a large-scale vegetable propagation business with greenhouse propagation operations in a 2.2 million square foot facility located in Delta, British Columbia. The facility is well suited to propagate flower-ready cannabis starter plants and will be the largest cannabis grower by number of plants in the world at a full capacity.

Propagation of cannabis plants is a highly technical and complicated process that can improve strain purity, eliminate contaminants and reduce diseases. By offering flower-ready plants to cannabis cultivators, growing operations are significantly simplified, the growing area allocated to harvest increased, resulting in meaningfully improved top line revenue and operating profits. PSC starter plants mitigate risk and allows cannabis cultivators to focus upon growing and processing flowering plants.

"The combination, of one of the most technically advanced greenhouse sites entering the cannabis industry and more than 40 years of propagation experience, is precisely what the cannabis industry requires to deliver clean, pure stock plants," said Nico Hache, Cultivation Consultant at Cannabis Compliance Inc. "The nursery plant mortality rate in the industry is very high due to lack of facility and technical expertise to grow at scale. PSC has a facility, the technical expertise and with a few modifications will change the way cannabis is grown. This expertise is what has been missing in the industry and will be welcomed by licensed producer."

About Cannabis Compliance Inc.

CCI, as one of Canada's original cannabis consulting firms, offers risk mitigation, due diligence, and regulatory licensing consulting services for commercial cannabis producers and resellers. CCI has extensive expertise in cultivation/horticulture, security designs/tender, facility designs/build-outs, quality assurance programs, and financial planning. CCI has strategic partnerships globally to secure investment partners for its clients, general contractors for buildouts, security tenders, equipment suppliers, media, government relations, and enterprise resource planning software. For over a decade, CCI's experienced team has been involved in commercial cannabis operations in Canada delivering proven results for their clients.

About PUF Ventures Inc.

PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies: AAA Heidelberg, Solaris Nutraceuticals Pty Ltd., and Natures Hemp Corp., and is actively pursuing other opportunities within the industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., an advanced applicant for an ACMPR license. Solaris Nutraceuticals is building the largest medical cannabis greenhouse in the Southern Hemisphere. For more information please visit: www.puf.ca.

ON BEHALF OF THE BOARD OF DIRECTORS

Derek IvanyPresident & CEO

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.

SOURCE PUF Ventures

View original content with multimedia: http://www.newswire.ca/en/releases/archive/July2018/05/c7419.html

SOURCE: PUF Ventures
PUF Ventures Inc., E: [e-mail], T: [phone]

Copyright (C) 2018 CNW Group. All rights reserved.




Chart not available

[grunt1]

PUF Ventures Inc. Signing of Arrangement Agreement
24 May 2018 16:05 ET
CNW Group
PUF Ventures Inc. Signing of Arrangement Agreement

PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), announces that, further to its news release of April 4, 2018, it has entered into an arrangement agreement (the "Arrangement Agreement") dated May 18, 2018 with its subsidiary Natures Hemp Corp. ("Natures Hemp") whereby the Company will transfer the assets (the "Assets"), being the business of development of cannabidiol extraction from seeds and other plant parts for the creation of high quality oils and flours, proprietary hemp base food and medicinal products into Natures Hemp by way of a plan of arrangement (the "Arrangement") pursuant to Division 5 of Part 9 of the Business Corporations Act (British Columbia), and Natures Hemp will become a reporting issuer in the Provinces of British Columbia, Alberta and Ontario upon completion of the Arrangement.

The purpose of the Arrangement is to allow the Company to divest itself of the Assets to Natures Hemp, enabling the Company to focus on the cultivation and future sales of cannabis with both THC and CBD and other vertically integrated products concerning cannabis. Natures Hemp will have a diversified management team, with special focus on hemp-related products, isolate extractions and related nutraceutical and medicinal products.

The Arrangement will be subject to the approval of the Supreme Court of British Columbia, as well as approval by the PUF shareholders at a special meeting to be held on Tuesday, August 7, 2018 (the "Meeting"). Pursuant to the Arrangement, PUF will distribute 17,500,000 (100%) of the common shares of Natures Hemp (the "Natures Hemp Shares") it receives to the PUF shareholders on a pro rata basis. The PUF shareholders will be entitled to receive one Natures Hemp Share in exchange for approximately every four (4) common shares of PUF held as at June 18, 2018 (the "Record Date"). There will be no change in shareholders' holdings in PUF as a result of the Arrangement. No outstanding warrants or options of PUF will be transferred over to Natures Hemp.

Following completion of the Arrangement, (i) Natures Hemp will hold the Assets transferred to it by PUF, (ii) Natures Hemp will become a reporting issuer in the Provinces of British Columbia, Alberta and Ontario, intends to apply for listing on the Canadian Securities Exchange (the "Exchange"), and must meet the listing requirements of the Exchange. (iii) each PUF shareholder will continue to be a PUF shareholder, (iv) all the PUF shareholders will have become shareholders of Natures Hemp, and (v) PUF will retain its working capital for its Assets, and remain listed on the Canadian Securities Exchange and will continue to trade under the trading symbol, PUF, as a consumer products - biotechnology/pharmaceuticals company.

Details of the proposed Arrangement will be provided in a Management Information Circular that will be mailed to all the PUF shareholders as at the Record Date. At the Meeting, the PUF shareholders will be asked to vote on a special resolution approving the Arrangement. The PUF shareholders of record as at the Record Date will be eligible to vote on the Arrangement. The Arrangement will be posted on SEDAR under the profile of PUF.

The effective date of the Arrangement is expected to be in September 2018. A further press release will be issued by the Company with additional details regarding the Arrangement and when the exact effective date is known.

Additionally, Natures Hemp is in the process of raising funds by way of special warrant financings. It is expected that the special warrants will be converted into shares of Natures Hemp after the Meeting.

About PUF Ventures Inc.

PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies: AAA Heidelberg, Solaris Nutraceuticals Pty Ltd., and Natures Hemp Corp., and is actively pursuing other opportunities within the industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., a private Ontario company and advanced applicant for an ACMPR license. Solaris Nutraceuticals is building the largest medical cannabis greenhouse in the Southern Hemisphere. For more information please visit: www.puf.ca.

ON BEHALF OF THE BOARD OF DIRECTORS

Derek Ivany President & CEO

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Forward Looking Statements

Statements in this news release that are forward-looking statements are subject to various risks and uncertainties concerning the specific factors disclosed here and elsewhere in PUF's periodic filings with Canadian securities regulators. When used in this news release, words such as "will, could, plan, estimate, expect, intend, may, potential, believe, should, aware" and similar expressions, are forward-looking statements.

Forward-looking statements may include, without limitation, statements including statements related to PUF's transactions and business related to cannabis and future news releases.

Although PUF has attempted to identify important factors that could cause actual results, performance or achievements to differ materially from those contained in the forward-looking statements, there can be other factors that cause results, performance or achievements not to be as anticipated, estimated or intended, including, but not limited to: dependence on obtaining regulatory approvals; investing in target companies or projects which have limited operating history or when very limited due diligence was performed or may be engaged in activities currently considered illegal under US Federal laws; change in laws; limited operating history; reliance on management; requirements for additional financing; competition; hindering market growth and state adoption due to inconsistent public opinion and perception of the medical-use and adult-use marijuana industry; and regulatory or political change.

There can be no assurance that such information will prove to be accurate or that management's expectations or estimates of future developments, circumstances or results will materialize. As a result of these risks and uncertainties, the results or events predicted in these forward-looking statements may differ materially from actual results or events.

Accordingly, readers should not place undue reliance on forward-looking statements. The forward-looking statements in this news release are made as of the date of this release. PUF disclaims any intention or obligation to update or revise such information, except as required by applicable law, and PUF does not assume any liability for disclosure relating to any other company mentioned herein.

PUF Ventures Inc., E: [e-mail], T: [phone]

SOURCE PUF Ventures

View original content with multimedia: http://www.newswire.ca/en/releases/archive/May2018/24/c8107.html

SOURCE: PUF Ventures
PUF Ventures Inc., E: [e-mail], T: [phone]

Copyright (C) 2018 CNW Group. All rights reserved.

[grunt1]

PUF Ventures Forms Colombian Subsidiary to Pursue International Opportunities
04 May 2018 08:30 ET
CNW Group
PUF Ventures Forms Colombian Subsidiary to Pursue International Opportunities

PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), an advanced Access to Cannabis for Medical Purposes Regulations ("ACMPR") license applicant, is pleased to announce the formation of a wholly owned subsidiary Pure Grow Medicinals S.A.S. in Colombia to pursue additional international opportunities in the cannabis industry.

"Colombia is in the early stages of legalizing cannabis for medicinal and export purposes, and represents a strategic opportunity for PUF" said Derek Ivany, President and CEO of the Company. "It is a cannabis friendly jurisdiction where we have established local business relationships. We are in discussions and conducting due diligence on several projects with significant potential. By leveraging our experience in other international markets, we will ensure the success of Pure Grow Medicinals."

Medical cannabis was formally legalized in Colombia in 2015. Like Canada, local producers must obtain licenses from the government for the cultivation of psychoactive and non-psychoactive plants. Due to its proximity to the equator, Colombia has the ideal natural environmental to grow many different crops including cannabis. Plants are grown in open-air greenhouses, under a 12-hour sun cycle, throughout the year, and there is ample access to natural water sources. A minimal requirement for electricity and access to water are substantial cost advantages making Colombia one of the lowest cost cannabis producers in the world.

Internationally, PUF Ventures currently owns a 35 percent stake in Solaris Nutraceuticals, a private company based in Australia which is building a 1.2 million sq. ft., hi-tech, ultra-efficient, large-scale cannabis greenhouse in New South Wales, Australia. A potential project in Colombia represents a second international project to be undertaken by PUF Ventures.

About PUF Ventures Inc.

PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies: AAA Heidelberg, Solaris Nutraceuticals Pty Ltd., and Natures Hemp Corp., and is actively pursuing other opportunities within the industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., an advanced applicant for an ACMPR license. Solaris Nutraceuticals is building the largest medical cannabis greenhouse in the Southern Hemisphere. For more information please visit: www.puf.ca.

[Expresso123]

Australian Governments to Streamline Access to Medical Cannabis

https://finance.yahoo.com/news/australian-governments-streamline-access-medical-204400092.html?.tsrc=applewf

[grunt1]

News Story



PUF Ventures Provides Update to Spin Out Company Cannvas MedTech Inc.
18 Apr 2018 08:30 ET
CNW Group
PUF Ventures Provides Update to Spin Out Company Cannvas MedTech Inc.

PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), an advanced Access to Cannabis for Medical Purposes Regulations ("ACMPR") license applicant, is pleased to provide an update regarding its spin out company Cannvas MedTech Inc.'s ("MTEC" or the "Cannvas") Plan of Arrangement which closed on January 16, 2018.

The shareholders of PUF as at the record date of October 4, 2017 were eligible to receive one MTEC share for every seven shares of PUF held. The Plan of Arrangement closed on January 16, 2018, and the MTEC shares were distributed in anticipation to a listing on the Canadian Stock Exchange (the "CSE"). The Cannvas executive team has been working closely with the CSE and is in the final stages of listing.

"The pending listing on the CSE for the spinout of our non-core asset Vapetronix, which is now Cannvas, is another prime example of how to create value for our shareholders," said Derek Ivany, President and CEO of PUF. "I believe Cannvas is on its way to become a leading health sciences company within the cannabis space. I congratulate Shawn Moniz and Steve Loutskou for their hard work and dedication with Cannvas, and I look forward to the company's public listing to unlock real value to PUF shareholders."

In the first quarter of 2018, the executive team at Cannvas made considerable progress to position the company as a leading business technology company within the health sciences industry. Cannvas designs and builds customer-centric technology platforms that enable partners to harness the power of data to truly understand their customers. Their first product to be launched in 2018 is a dynamic educational platform for the cannabis space. Here are additional milestones achieved by the Cannvas team:
-- In the final stages of listing on the CSE;
-- Setup several complimentary online brands: Cannvas Creative,
Cannvas Data, Cannvas Connect, and techonesixty,
-- Cannvas Creative, a marketing and branding agency which offers
services to clients to achieve growth that outperforms the
market, has been generating revenue since January 2018,
-- Secured various digital assets including several hundred
domains,
-- Initiated discussions with several leading organizations within
the health sciences and technology sectors to establish
partnerships,
-- Participating in several medical advisory and health innovation
boards.




Shawn Moniz, CEO of Cannvas, and Steve Loutskou, Chief Operation Officer, Global Markets, continue to work diligently with various government agencies working toward the listing on the CSE and other partnerships and networking advancements within the health sciences sector.

On April 4, 2018, PUF announced a second spin-out of non-core assets for its wholly owned subsidiary Natures Hemp Corp. ("Natures Hemp"). Like the Cannvas transaction, the Natures Hemp transaction will be completed by way of a Plan of Arrangement and a listing application to the CSE. Natures Hemp is a biotechnology and consumer products company that is unlocking the true value of hemp. By developing a new generation of plant-based, nutrient rich cannabidiol (CBD) food, beverage and healthcare related products, its goal is to introduce a premium brand of quality CBD products with an emphasis on health and wellness. The Plan of Arrangement will have to be approved by the shareholders of the Company and the Supreme Court of British Columbia.

About Cannvas MedTech Inc.

Cannvas Medtech is a leading business technology company within the health sciences space. We design and build customer- centric platforms that enable our partners to harness the power of data to truly understand their customers.

About PUF Ventures Inc.

PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies: AAA Heidelberg, Solaris Nutraceuticals Pty Ltd., and Natures Hemp Corp., and is actively pursuing other opportunities within the industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., an advanced applicant for an ACMPR license. Solaris Nutraceuticals is building the largest medical cannabis greenhouse in the Southern Hemisphere. For more information please visit: www.puf.ca.

ON BEHALF OF THE BOARD OF DIRECTORS

Derek IvanyPresident & CEO

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Company's future plans, objectives or goals, including words to the effect that the Company or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.

PUF Ventures Inc., E: [e-mail], T: [phone]

SOURCE PUF Ventures

View original content with multimedia: http://www.newswire.ca/en/releases/archive/April2018/18/c6248.html

SOURCE: PUF Ventures
PUF Ventures Inc., E: [e-mail], T: [phone]

Copyright (C) 2018 CNW Group. All rights reserved.

[grunt1]

MYM Nutraceuticals Inc., (CSE: MYM.CN) (MYM.CN) in response to an advanced Access to Cannabis for Medical Purposes Regulations ("ACMPR") license applicant and its strategic partners PUF Ventures Inc. (CSE: PUF) are pleased to announce the Australia based Solaris Nutraceuticals Pty Ltd, which is building the largest medical cannabis greenhouse southern hemisphere, has been awarded a $AUD2,500,000 Regional Jobs Investment Program (RJIP) grant, through Federal Department of Innovation, Industry & Science.

"We are co-investing with Solaris Nutraceuticals to make sure it (the medicinal cannabis facility) happens," said Kevin Hogan, Australian Member of Parliament. "Up to 280 jobs will be there one day providing this great new product that is needed by our community. We look forward to having the largest medicinal cannabis facility in the Southern Hemisphere soon in Casino."

"We are very honoured to be awarded this Federal Grant towards the construction of our 1,200,000 sq. f.t greenhouse," said Michael Horsfall, Co-founder and CEO of Solaris Nutraceuticals. "We have been overwhelmed with the generous support we have received from all levels of Government. We are working hard to deliver this project. We expect to create upwards of 300 to 500 direct and indirect jobs in the Northern Rivers Region from our greenhouse project. This will provide a significant boost to the local economy."

The new facility will be Australia's largest growing, manufacturing, processing and research facility in Australia. This is an innovative project which will help patients, create new jobs, complete further research and develop new products in the medical cannabis field.

The company is currently in the assessment stage for three licenses with the Office of Drug Control in Canberra.

Kevin Hogan, Member of Parliament: https://m.facebook.com/story.php?story_fbid=1694316460660111&id=356113427813761&refsrc=http%3A%2F%2Ft.co%2F4LMgCG1HkD&_rdr

"Getting financial support from the local government at this scale is unprecedented," said Rob Gietl, CEO of MYM. "We are very excited about the Northern rivers project and the economic impact it can have for the area and Solaris Nutraceuticals Inc."

The project is scheduled to break ground this Summer with phase one completed by the end of 2018. Project completion is scheduled for Q4 2019.

About Solaris Nutraceuticals (MYM owns 35%)

Solaris Nutraceuticals is an innovative medical technology company with headquarters in Sydney, Australia. It has proposed plans and applications with Office of Drug Control in Australia to build a 1.2 Million square foot glass house with a medical research center and manufacturing facility in the Northern Rivers Region of New South Wales Australia. Our corporate mission is to deliver an environmentally friendly, sun grown medicinal grade cannabis and on developing medicines and treatments for pain management along with a number of other medical conditions and specific plant based nutraceuticals. Our focus is on innovations that promote, support and deliver improvements in the quality, consistency and cost of medicines to our clients.

About MYM Nutraceuticals Inc.

MYM Nutraceuticals Inc. is an innovative company focused on acquiring Health Canada licenses to produce and sell high-end organic medicinal cannabis supplements and topical products. MYM has two production projects in Quebec that when completed will have over 1.5 million sf of production space. MYM is also a partner in a 1.2 million sf production project (Northern Rivers Project) in New South Wales, Australia. Australia is an exciting new market that has recently legalized medicinal cannabis. To ensure a strong presence and growth potential within the industry, MYM is actively looking to acquire complementary businesses and assets in the technology, nutraceuticals and CBD sectors. MYM shares trade in Canada, Germany and the USA under the following symbols: (CSE: MYM) (OTC:MYMMF) (FRA:0MY) (DEU:0MY) (MUN:0MY) (STU:0MY).

Here's to our Future Growth and Prosperity Together.

ON BEHALF OF THE BOARD

Rob Gietl, CEOMYM Nutraceuticals Inc.http://www.mymarijuana.ca

Keep up to date with MYM on our social media channels:

Twitter: @MYM_Nutra

Facebook: @mymcanada

Instagram: @MYM_Nutra

This news release may contain forward-looking statements based on assumptions and judgments of management regarding future events or results. Such statements are subject to a variety of risks and uncertainties which could cause actual events or results to differ materially from those reflected in the forward-looking statements. The company disclaims any intention or obligation to revise or update such statements. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company's Management's Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted on http://www.sedar.com .

This news release does not constitute an offer to sell or solicitation of an offer to buy any of the securities described herein and accordingly undue reliance should not be put on such. Neither the Canadian Securities Exchange (CSE or CNSX Markets), nor its Regulation Services Provider (as that term is defined in policies of the CSE), accepts responsibility for the adequacy or accuracy of this release.

This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein in the United States. The securities described herein have not been registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act"), or any state securities law and may not be offered or sold in the "United States", as such term is defined in Regulation S promulgated under the U.S. Securities Act, unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration requirements is available.

SOURCE MYM Nutraceuticals Inc.

View original content: http://www.newswire.ca/en/releases/archive/February2018/15/c7740.html

SOURCE: MYM Nutraceuticals Inc.
Investor Relations, Terry Brown, [phone], [e-mail]

Copyright (C) 2018 CNW Group. All rights reserved.




Chart not available


































Important Legal Notice: All market

[grunt1]

Cannvas Medtech Inc. Forms Technology Partnership with Blox Labs for Digital Marketing and Branding
01 Feb 2018 08:30 ET
CNW Group
PUF Ventures Inc. ("PUF" or the "Company") (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), and Cannvas Medtech Inc. ("MTEC") are pleased to announce the formation of a technology partnership between MTEC and Blox Labs Inc. (CSE: BLOX) (US OTC: BLLXF) (FSE: BR1B), a technology company specialized in decentralized ledger technology, smart contracts and blockchain development.

MTEC will use its extensive expertise in strategic creative marketing campaigns including SEO, digital branding and other related services to create a high-quality strategic communications campaign for Blox's investor base and partners as the it drives its business growth with multiple blockchain projects. The increased connectivity will facilitate the sharing of Blox news, projects and media through digital and mobile networks. This alliance also opens the door to exploring new and innovative digital business solutions.

"I would like to congratulate Shawn and Steve of MTEC upon their first contract after the January 16, 2018 completion of the plan of arrangement between PUF Ventures and Cannvas Medtech," said Derek Ivany, President and CEO of PUF Ventures. "This contract is the first of many and represents a significant milestone as the MTEC team works toward their upcoming listing on the Canadian Stock Exchange. It was a very successful for all at the 2018 Cantech Investor Conference held in Toronto yesterday."

"The Cannvas team is truly excited about our new partnership with BLOX. We have a dynamic team, we understand the marketplace, and we know that our experience designing strategic creative campaigns on a global scale will form the basis of a successful and enduring partnership," said Steve Loutskou, CSO at MTEC. "Our work is founded on strategic thinking and creative differentiation, with the addition of in-depth analytics which allows us to not only deliver effective campaigns but also provide significant and real return on investment for our partners."

Cannvas MedTech believes in the power of data to help build customer-centric initiatives in the medical technology sector. Millions of ideas are created every day, a fraction of those address an actual business need, and fewer still have the business plan to disrupt the status quo in becoming game changers in today's ever-changing markets. At Cannvas MedTech Inc. we focus our efforts towards data-driven business solutions that put the end user in the driver seat. From access to investors, target customers and industry-leading experts, our company enables other companies to scale and succeed as global industry leaders. For more information visit: www.cannvasmedtech.com.

About PUF Ventures Inc.

PUF Ventures Inc. is a growth oriented and diversified company focused on the international cannabis industry. It has ownership in several cannabis companies: AAA Heidelberg, Solaris Nutraceuticals Pty Ltd., and Natures Hemp Corp., and is actively pursuing other opportunities within the industry. PUF has an option to purchase 100% of AAA Heidelberg Inc., a private Ontario company and advanced applicant for an ACMPR license. Solaris Nutraceuticals is building the largest medical cannabis greenhouse in the Southern Hemisphere. For more information please visit: www.puf.ca.

ON BEHALF OF THE BOARD OF DIRECTORS

Derek IvanyPresident & CEO

No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.

Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer's future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties.

SOURCE PUF Ventures

View original content with multimedia: http://www.newswire.ca/en/releases/archive/February2018/01/c2526.html

SOURCE: PUF Ventures
PUF Ventures Inc., E: [e-mail], T: [phone]

Copyright (C) 2018 CNW Group. All rights reserved.

[CaptStockWolf]

Looks like a full scale pump and dump in effect. Now in dump modes

[returns]

READ: TTCM NEXT FACEBOOK!

TAUTACHROME.COM "ONCE IN A LIFETIME OPPORTUNITY"

[grunt1]

does anybody know where this stock(business) is headed for.thanks

[ma61]

Dear Alphastox Subscribers,

I have been getting a lot of questions on a company we’ve been covering for quite a while now, PUF Ventures (CSE:PUF) and wanted to make sure I sent everyone a quick note. Although PUF.C has been quite slow in the market, I think that will soon change. The company has been progressing nicely operationally and I’m hopeful that 2016 will be the year we can see all their hard work finally come to fruition.

Over the last twelve months, the company has made some significant strides forward: Their AAA Heidelberg cannabis facility in London, Ontario passed their security clearance and entered into the review stage. Now that’s a huge step forward that I don’t think the market quite realized. At an $1,800,000 market cap, that’s where I see the biggest upside for investors. Many experts in the field have already told me that gaining security clearance is the hardest part in the process of securing an MMPR license in Canada. Now that that’s finally behind the company, management believes it’s only a matter of time before they get their license. So what’s a license worth? Judging from other licensed public companies on the exchange today like Aurora Cannabis (CSE:ACB), Canopy (TSXV:CGC), Organigram (TSXV:OGI) etc., many can argue that an MMPR license is worth around $10,000,000 or over 5X the value of where PUF.C is currently trading at today. Now there’s obviously no guarantees of that happening but with security clearance granted, the company is well on its way towards achieving their goal and since I have a very large share position in the company myself, I’m hoping they can get it over the line.

Not only that, but PUF also completed the purchase of a 9.7 acre parcel of land in Whatcom County, Washington. PUF purchased the property for around USD $1.2 million and has a USD $1.08 million mortgage on it which is due on May 31st, 2017. Since the property is licensed, they’re looking to become a landlord and lease-out the space to potential licensed growers. Yari and his team are also working hard to secure a potential JV/strategic partner so stay tuned for that news.

VapeTronix - The company announced that it’s introducing a premium e-liquid/e-juice product line to its existing 1313 brand of e-cigarettes. Purchase orders are already coming in but I’m hoping to see a much larger order come in shortly.

At less than an $1,800,000 market cap, I think investors have more than one reason to keep PUF.C on their radar screens. If they get an MMPR license, I could easily see this stock trading at much higher levels and giving investors a significant reward on their investment. Not only that, but as they look to secure a JV partner in Washington and continue to increase revenue on their e-cigarette line, this is a story that could trade based on a revenue multiple over time. Now, it’s obviously very early stage and probably too early to talk about that now but I wanted to keep it in the back of your mind as the sector and company continues to develop. With an exciting pipeline in the mix and if they’re able to achieve some of their short-term goals, PUF could easily outweigh many of our 2016 expectations.

Now that everyone’s back at their desks and ready to work, I expect a lot more news to come in short order so stay tuned. I should also have a more thorough report to come once I speak to management but in the meantime, please feel free to get in touch with me anytime. I look forward to hearing from you.

Best,
Etienne